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ABSTRACT OF DISSERTATION

CONTINUOUS TIME MULTI-STATE MODELS FOR INTERVAL CENSORED DATA
Continuous-time multi-state models are widely used in modeling longitudinal data
of disease processes with multiple transient states, yet the analysis is complex when
subjects are observed periodically, resulting in interval censored data. Recently, most
studies focused on modeling the true disease progression as a discrete time stationary
Markov chain, and only a few studies have been carried out regarding non-homogenous
multi-state models in the presence of interval-censored data. In this dissertation, several
likelihood-based methodologies were proposed to deal with interval censored data in
multi-state models.
Firstly, a continuous time version of a homogenous Markov multi-state model
with backward transitions was proposed to handle uneven follow-up assessments or
skipped visits, resulting in the interval censored data. Simulations were used to compare
the performance of the proposed model with the traditional discrete time stationary
Markov chain under different types of observation schemes. We applied these two
methods to the well-known Nun study, a longitudinal study of 672 participants aged ≥ 75
years at baseline and followed longitudinally with up to ten cognitive assessments per
participant.
Secondly, we constructed a non-homogenous Markov model for this type of panel
data. The baseline intensity was assumed to be Weibull distributed to accommodate the
non-homogenous property. The proportional hazards method was used to incorporate risk
factors into the transition intensities. Simulation studies showed that the Weibull
assumption does not affect the accuracy of the parameter estimates for the risk factors.
We applied our model to data from the BRAiNS study, a longitudinal cohort of 531
subjects each cognitively intact at baseline.
Last, we presented a parametric method of fitting semi-Markov models based on
Weibull transition intensities with interval censored cognitive data with death as a
competing risk. We relaxed the Markov assumption and took interval censoring into

account by integrating out all possible unobserved transitions. The proposed model also
allowed for incorporating time-dependent covariates. We provided a goodness-of-fit
assessment for the proposed model by the means of prevalence counts. To illustrate the
methods, we applied our model to the BRAiNS study.
KEYWORDS: Longitudinal Data, Multi-State Model, Interval Censoring, Markov,
Semi-Markov, NUN Study, BRAiNS Study
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Chapter 1 Introduction
1.1

Overview
In most longitudinal medical studies on progression of healthy individuals to

chronic diseases, such as cancer, AIDS, and dementia, the nature of the development is
often expressed in terms of distinct health stages, where patients are observed at certain
time points and covariate information is collected at several occasions.
Multi-state models (MSM), as generalizations of survival and competing risks
models, are the most common models for describing longitudinal failure time data. These
models have wide application in modeling the complex evolution of chronic diseases. In
epidemiology, multi-state models are used to represent the trajectory of subjects through
different discrete states, generally including clinical disease and death.
Handling interval-censored data is considerably more difficult, both analytically
and numerically, in MSMs than in survival models and competing risk models, especially
for more complex models. The complexity of a MSM mainly depends on the number of
states and the possible transitions from these states. The more complex the model, the
more difficult it is to define and evaluate the likelihood. For the homogeneous Markov
model (HMM), the solution to this problem has long been known, although not widely
used in medical research or epidemiology. For non-homogenous Markov Models
(NHMM) or semi-Markov models, the problem of inference with interval-censored data
is considerably more difficult. One key point is that transition probabilities can be
expressed simply in terms of transition intensities in HMM but not in more general multistate models. Another key point is that that interval-censoring in multi-state models gives
rise to a new difficulty, which does not arise in survival models. Generally, several paths
1

are possible for transitioning from state h to state j between time s and time t, so it is not
known which paths occurred [1].
We aim to develop flexible and powerful statistical methods to address the issue
of interval-censored data in the application of MSM. In the following, we will introduce
the Nun Study and BRAiNS Study, a review of multi-state models, the problems
encountered with current methods, and the methodologies we propose to address this
problem.
1.2

Background of the Nun Study
The Nun Study is a well-known cohort study designed to assess the influence of

early life exposures and cognitive ability on the development of Alzheimer-type dementia
and pathology in late life. 672 members of the School Sisters of Notre Dame religious
congregation born between 1890 and 1916 and living in the Midwestern, eastern, and
southern United States agreed to annual cognitive and functional assessments, and to
brain donation [2]. The Nun Study was established at the University of Kentucky in 1991
and moved to the University of Minnesota in 2008. Only the data collected until 2008 is
used in this dissertation.
Both time-independent and time-dependent covariates were recorded. Time
independent covariates were recorded only once; for example, education level and the
gene-related factor, Apolipoprotein E4 carrier status. Time dependent covariates were
recorded at each of the follow up assessments.
At each assessment, the cognitive status of each subject was categorized into
several different states. In our study, we focused on three cognitive states: Not Serious
2

Impairment (NSI), Global Impairment (GI) and Dementia. A fourth state, Death, was also
included in our model as an important competing risk for states GI and Dementia. The
transition flow among these four states is shown in Figure 1.1.
Subject follow-up was planned to last until death. However, some subjects were
still alive at the end of the data collection period which results in right censored data. The
time to each cognitive state and dementia is subject to interval censoring, due to the fact
that each assessment was taken at irregularly spaced discrete time points.
1.3

Background of the BRAiNS Study
The Biologically Resilient Adults in Neurological Studies (BRAiNS) began

enrolment in 1989 at the Sanders Brown Center on Aging at the University of Kentucky.
The purpose of the BRAiNS project is to study normal aging of the brain in contrast to
Alzheimer’s disease. Subjects are recruited in phases and receive annual assessments
with brain donation at death. All subjects were cognitively intact at study entry.
Using results of annual assessments, a subject was placed into one of several
mutually exclusive clinical cognitive states. In our studies, we focused on the transitions
between the following states: normal, MCI, dementia and death. Figure 1.2 presents the
transition flow and the frequencies for each possible transition.
Right-censored data arises due to subjects’ early drop out or the fact that some
subjects were still in the normal or MCI state when data collection for the current study
ended. Transition time to MCI and dementia are all interval-censored. Cognitive
assessments were taken at discrete time points, thus the exact transition times to MCI and
Dementia were unknown.
3

1.4

Multi-State Models

A multi-state model (MSM) is a model for a stochastic process allowing individuals to
move among a finite number of states. In biomedical applications, the states might be based
on clinical symptoms (e.g. bleeding episodes), biological markers (e.g. CD4 T-lymphocyte
cell counts; serum immunoglobulin levels), severity levels of the disease (e.g. stages of
cancer or HIV infection) or a non-fatal complication in the course of the illness (e.g. cancer
recurrence). A change of state is called a transition, or an event. States can be transient, if
the transitions to and from the state are possible, or absorbing, if no transitions can emerge
from the state (for example, death) [3-6].
1.4.1

Multi-State Process
Continuous-time multi-state models are based on the theory of a multi-state

process, which is assumed to be a stochastic process X(t) with a finite state space 𝑆𝑆 =
{1,2, … , 𝐾𝐾}. It can be fully characterized by its transition probability matrix or its

transition intensity matrix. The transition probability matrix 𝑃𝑃(𝑠𝑠, 𝑡𝑡) is a K × K matrix, and
its (ℎ, 𝑗𝑗)th entry is

𝑝𝑝ℎ𝑗𝑗 (𝑠𝑠, 𝑡𝑡) = 𝑃𝑃(𝑋𝑋(𝑡𝑡) = 𝑗𝑗|𝑋𝑋(𝑠𝑠) = ℎ, 𝐻𝐻𝑠𝑠− ) , 𝑠𝑠 < 𝑡𝑡

𝑃𝑃ℎ𝑗𝑗 (𝑠𝑠, 𝑡𝑡) represents the probability of the process being in state j at time 𝑡𝑡 given its state ℎ
at time 𝑠𝑠 and the history of the process before time 𝑠𝑠, 𝐻𝐻𝑠𝑠− .

The transition intensity matrix measures the instantaneous hazard of transition to

other states given the current state. The (ℎ, 𝑗𝑗)th entry of the transition intensity matrix
𝑄𝑄(𝑡𝑡) at time 𝑡𝑡 has the form:

𝛼𝛼ℎ𝑗𝑗 (𝑡𝑡) = 𝑙𝑙𝑙𝑙𝑙𝑙 𝑃𝑃(𝑋𝑋(𝑠𝑠 + ∆𝑠𝑠) = 𝑗𝑗|𝑋𝑋(𝑠𝑠) = ℎ, 𝐻𝐻𝑠𝑠− ) /∆𝑡𝑡 , 𝑖𝑖𝑖𝑖 ℎ ≠ 𝑗𝑗
∆𝑡𝑡→0

4

and
𝛼𝛼ℎℎ (𝑡𝑡) = − ∑𝑗𝑗≠ℎ 𝛼𝛼ℎ𝑗𝑗 (𝑡𝑡).

Different model assumptions can be made about the dependence of the transition
rates on time. Examples include:
1.

Time homogeneous models: the intensities are constant over time t.

2.

Markov models: the transition intensities only depend on the history of the
process through the current state.

3.

Semi-Markov models: future evolution not only depends on the current
state ℎ, but also on the entry time 𝑡𝑡ℎ into state h. Therefore, we may consider

intensity functions of the general form 𝛼𝛼ℎ𝑗𝑗 (𝑡𝑡, 𝑡𝑡 − 𝑡𝑡ℎ ) or, as the special
homogeneous case 𝛼𝛼ℎ𝑗𝑗 (𝑡𝑡 − 𝑡𝑡ℎ ).
1.4.2

Markov Models
The process (𝑋𝑋(𝑡𝑡), 𝑡𝑡 ≥ 0) is Markovian if the transition probabilities and

transition intensities are independent of the past history, that is, for any 𝑠𝑠, 𝑡𝑡 with 0 ≤ 𝑠𝑠 <

𝑡𝑡, we have
and

𝑃𝑃(𝑋𝑋(𝑡𝑡) = 𝑗𝑗| 𝑋𝑋(𝑠𝑠) = ℎ, 𝐻𝐻𝑠𝑠− ) = 𝑃𝑃(𝑋𝑋(𝑡𝑡) = 𝑗𝑗| 𝑋𝑋(𝑠𝑠) = ℎ)

𝛼𝛼ℎ𝑗𝑗 (𝑡𝑡) = �

lim P(𝑋𝑋(𝑡𝑡 + ∆𝑡𝑡) = 𝑗𝑗|𝑋𝑋(𝑡𝑡) = ℎ) /∆𝑡𝑡

∆𝑡𝑡→0

− � 𝛼𝛼ℎ𝑘𝑘 (𝑡𝑡)
𝑘𝑘≠ℎ

𝑗𝑗 ≠ ℎ

𝑗𝑗 = ℎ

For a Markov process, the future of the process after time 𝑡𝑡 depends only on the

state occupied at time 𝑡𝑡. Under the Markov assumption, the transition probabilities can
5

be calculated from the intensities by solving the forward Kolmogorov differential
equation [4].
1.4.3

Semi-Markov Models
For the semi-Markov model, the transition intensities of the process depend on the

time elapsed at the current state. These processes are generalizations of both continuous
and discrete parameter Markov processes with countable state spaces. An issue in using a
semi-Markov model is identifying the time origin, the exact time of entrance into the
initial state.
1.4.4

Modeling Intensities
Covariates in multi-state models are often incorporated through the transition

intensity functions to explain differences among individuals in the course of the disease
progression. A popular choice is the proportional hazards model, which has the following
form
𝛼𝛼ℎ𝑗𝑗 (𝑡𝑡|𝒁𝒁𝑖𝑖 ) = 𝛼𝛼ℎ𝑗𝑗,0 (𝑡𝑡)𝑒𝑒𝑒𝑒𝑒𝑒�𝜷𝜷𝑇𝑇ℎ𝑗𝑗 𝒁𝒁𝑖𝑖 �.

In an MSM, the transition intensities define the hazard of a movement from one
state to another. These functions can also be used to determine the mean sojourn time in a
given state and the number of individuals in different states at a certain moment.
1.5

A Review of Methods for Dealing Interval Censoring Data
Markov models are popular tools for analysis of longitudinal data, since the

assumption simplifies statistical modelling. According to this assumption, the transition
to the next state only depends on the current state, ignoring any previous history of the
process.
6

Only a few studies have been carried out regarding NHMM in the presence of
interval-censored data. Most of the literature is limited to the three-state models. One of
the first such studies was that of Hsien, et al.[7], who examined a three-state progressive
non-homogenous Markov model with the incorporation of Weibull distribution or the
piecewise exponential model to accommodate non-constant transition rates. Hout, et al.
[8] extended this approach by including the possibility to move directly from the health
state to the death state, resulting in an illness-death model. Both the Weibull distribution
and the piecewise-constant model are investigated to deal with the time dependency of
the intensities. The model is extended by using logistic regression models for both
misclassification probabilities and the latent distribution of the states at baseline.
Nonparametric approaches to NHMMs may follow two paths: one is the completely nonparametric approach as a generalization of the Turnbull approach; the other implies a
restriction to smooth intensities models. The first explicit non-parametric treatment of
interval-censored observations from a MSM in continuous time is given by Frydman,
who studied a progressive three-state model [9], and a special case of the illness-death
model [10]. The penalized likelihood approach already proposed for interval-censored
survival data [11] was extended to a three-state progressive model by Joly and
Commenges [12] and to the illness-death model by Joly, et al. [13].
However, in many applications, the Markov assumption might not be appropriate
and may lead to biased conclusions. A semi-Markov model would be more appropriate in
this case, to allow the transition intensities of the process to depend not only on the
current state, but also the time elapsed in the current state.

7

There has not been much literature on the application of semi-Markov models for
interval censored data. Satten [14] proposed non-parametric estimators based on an EM
algorithm in the case of a unidirectional model without covariates. Foucher [15, 16]
defined a semi-Markov model based on a generalized Weibull hazard function. The
model is defined by the probability of transition among states and, independently, the
holding time it takes for that transition to occur. The holding times of the underlying
process are assumed to follow a generalized Weibull distribution. Kapetanakis [17]
recently presented a parametric method of fitting semi-Markov models with piecewiseconstant hazards in the presence of left, right, and interval censoring.
Our research is motivated by two longitudinal studies investigating cognitive
ability in the older population, the Nun Study and BRAiNS Study. Previous work was
carried out by Salazar, et al. [18] , Yu, et al. [19], Abner, et al. [20] and Kryscio, et al.
[21, 22]. Salazar, et al. [18] proposed a multi-state Markov model with shared random
effects to estimate the one-step transition matrix. In their model, polytomous logistic
regression models with shared random effects were first introduced to account for the
correlations between observations among the same subjects. The likelihood functions
were constructed by integrating the random effect out. Their simulation study showed the
approximation to their integral produced reasonable estimates of the unknown model
parameters in the one-step transition matrix, and that these parameter estimates are robust
across a spectrum of distributions for the shared random effect. However, the model
approximated the joint distribution of the response variable using a conditional
distribution given the baseline outcome of the response variable, which could produce a
so-called “baseline confounding” problem. Yu, et al. [19] extended Salazar's model to
8

include the information of the baseline state to address this limitation by accommodating
the baseline confounding in the Markov model using shared random effects approaches.
However, under a shared random effects model, separating the baseline distribution from
the overall model likelihood can lead to underestimation of the effects of risk factors on
the one-step transitions. Abner, et al. [20] expanded Salazar's model to investigate the
transient nature of MCI by including a clinically determined MCI state as an outcome.
The multistate Markov chain with three transient states (normal cognition, aMCITB, and
mMCITB), one quasi-absorbing state (MCICC), and two absorbing state (death and
dementia) was used to model the probability of maintaining the current state or moving to
a different state at the next assessment. Here aMCITB and mMCITB represent amnestic
and mixed forms of the MCI state as determined by cognitive tests (test based). However,
transitions to MCICC and dementia states are still assumed to have occurred on the date
of assessment. The model also ignores any transitions among the transient states between
regularly scheduled assessments. While these methods are all easy to implement and
quite useful, several assumptions need to be satisfied. First, time intervals between two
consecutive assessments are required to be equally spaced. However, in many
observational longitudinal studies, it is very common to have unequally spaced
longitudinal data resulting from uneven assessments or skipped visits. Second, the exact
transition times are assumed to occur exactly at the discrete assessment time points since
modeling assumptions do not permit the inclusion of interval censoring-type approaches.
In reality, interval censored data commonly exist and transitions may take place at any
time. Third, those models assume no censored states exist. They assume all possible
transitions could be observed between two consecutive assessments. Any transitions
9

among the transient states during the follow-up assessments are ignored since those
models use only the state of the individual at the next assessment. In fact, in most studies
we might not be able to tell whether a patient went through other transient states before
the following assessment. From the above, the Markov chain model does have some
limitations since they rely on a discrete-time model.
Kryscio, et al. [21, 22] applied a semi-Markov model, which is defined by the
probability of the transition among states and independently the holding time it takes for
that transition to occur. The model is useful to identify risk factors for transitions to MCI
and dementia by adjusting the competing risk of death. However, this model is still based
on a discrete model, and has the limitation of ignoring interval-censored transition times
or unobserved transitions between successive assessments.
1.6

Outline of the Dissertation
The remainder of this dissertation is organized as follows.
In Chapter 2, a continuous time version of homogenous Markov multi-state model

with backward transitions is proposed to handle the uneven follow-up assessments or
skipped visits, resulting from the interval censored data. Simulations are used to compare
the performance of the proposed model with the traditional discrete time stationary
Markov chain under different types of observation schemes.
In Chapter 3, we construct a non-homogenous Markov model for this type of
panel data. The baseline intensity is assumed to be Weibull distributed to accommodate
the non-homogenous property. The proportional hazards method is used to incorporate
risk factors into the transition intensities.
10

In Chapter 4, we present a parametric method of fitting semi-Markov models
based on Weibull transition intensities to interval censored cognitive data with death as a
competing risk. We relax the Markov assumption and take into account interval
censoring by integrating out all possible unobserved transitions. The proposed model also
allows for incorporating time-dependent covariates. A goodness-of-fit assessment is
provided for the proposed model by the means of prevalence counts.
Finally in Chapter 5, we summarize the work and offer some potential areas for
future study.

11

Figure 1.1 Transition flows among the four states recorded in the Nun Study data

Figure 1.2 Transition flows among the four states recorded in the BRAiNS data

12

Chapter 2 A Comparison of Discrete-time and Continuous-time Multi-state Models
2.1

Introduction
In most longitudinal medical studies on the progression of healthy individuals to

chronic diseases, such as cancer, AIDS, and dementia, the natural development is often
expressed in terms of distinct states. The analyses in such studies where individuals may
transition among several states are often performed by using multi-state models (MSMs).
There are two major types of multi-state models in literature, one is based on discretetime Markov chain, and the other one is based on continuous-time Markov process.
These two types of modeling techniques are related in certain ways, and both enable
researchers to study transitions between different disease states simultaneously. However,
the two types of models are constructed under different assumptions, and might generate
different results and conclusions under certain cases. Thus, researchers need to be careful
when deciding which models to use in real data applications.
Multi-state models based on the discrete-time Markov chain have become popular
in analyzing longitudinal data collected in chronic disease studies. Such models are also
called Markov chain transitional models [23] in the literature. Kryscio, et al. [24] used a
Markov chain model to identify risk factors associated with transitions from cognitively
normal to various forms of mild cognitive impairment (MCI) and then from MCI into
early dementia, with death before dementia as a competing state. A series of polytomous
logistic models were used to model the one step transition probabilities, and they focused
on the effects of baseline age, education, sex, family history of dementia, and APOE4
status on the transition probabilities.
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Use of Continuous-time MSMs has grown quickly in literature. A continuoustime MSM is a model for a continuous time stochastic process allowing individuals to
move among a finite number of states [4]. There exists an extensive literature on
Continuous-time MSMs [4-6, 25]. Applications of continuous-time MSMs can be found
in liver cirrhosis [26], dementia [11-13, 27], etc.
In real data applications, the observation schemes vary among different studies. In
some studies, investigators are able to collect the data at equally spaced time points, for
example once a month or once a year. In this case, the resulting longitudinal data will be
evenly spaced. In other studies, collecting the data at equal time intervals is unrealistic; in
these cases the longitudinal data will be unevenly spaced. Both types of MSMs are
widely used in applications to model similar longitudinal data without considering the
observation schemes. In this manuscript we will conduct a comparison study between the
two types of models. To the best of our knowledge, there are few studies in the literature
that compares these methods.
The rest of this chapter is structured as follows. In Section 2.2, the discrete-time
MSM and continuous-time MSM are introduced respectively. In Section 2.3, a simulation
study is conducted to compare the two modeling methods under different observation
schemes. Section 2.4 applies the two methods to a real dataset, the Nun study. Conclusion
and discussion are provided in Section 2.5.
2.2

Discrete-time and continuous-time multi-state models
For a chronic disease with 𝐾𝐾 possible outcome states, we could write the

underlying disease process as 𝑋𝑋(𝑡𝑡) ∈ {1,2, … , 𝐾𝐾}, 𝑡𝑡 ≥ 0. Here, the value of 𝑋𝑋(𝑡𝑡) denotes
the occupied disease state at time 𝑡𝑡. Suppose an individual has observations at time
14

points 𝑻𝑻 = ( 𝑡𝑡0 , 𝑡𝑡1 , … , 𝑡𝑡m ), we write 𝑿𝑿 = (𝑋𝑋0 , 𝑋𝑋1 , … , 𝑋𝑋𝑚𝑚 ) the corresponding occupied

states such that 𝑋𝑋𝑙𝑙 = 𝑋𝑋(𝑡𝑡𝑙𝑙 ), 𝑙𝑙 = 1, 2, … , 𝑚𝑚. The initial state 𝑋𝑋0 is usually given.
2.2.1

Discrete-time multi-state model
In a discrete-time multi-state model, the longitudinal data are modeled through a

joint probability mass function 𝑃𝑃(𝑋𝑋0, 𝑋𝑋1 , … , 𝑋𝑋𝑚𝑚 ). The observation time points 𝑻𝑻 =

( 𝑡𝑡0 , 𝑡𝑡1 , … , 𝑡𝑡m ) are ignored under the assumption that the data are evenly spaced. In most
applications, the outcome data (𝑋𝑋0 , 𝑋𝑋1 , … , 𝑋𝑋𝑚𝑚 ) are assumed to follow a discrete-time

Markov chain, in which we have

𝑃𝑃(𝑋𝑋0 , 𝑋𝑋1 , … , 𝑋𝑋𝑚𝑚 ) = 𝑃𝑃(𝑋𝑋0 ) × 𝑃𝑃(𝑋𝑋1|𝑋𝑋0) × ⋯ × 𝑃𝑃(𝑋𝑋𝑚𝑚 |𝑋𝑋𝑚𝑚−1).

The one-step transition probability from state ℎ to state 𝑗𝑗 at 𝑙𝑙th step can be written as
𝑃𝑃ℎ𝑗𝑗,𝑙𝑙 = 𝑃𝑃(𝑋𝑋𝑙𝑙 = 𝑗𝑗|𝑋𝑋𝑙𝑙−1 = ℎ).

Thus, the joint probability mass function 𝑃𝑃(𝑋𝑋0 , 𝑋𝑋1 , … , 𝑋𝑋𝑚𝑚 ) can be characterized by the
one-step transition probability matrix

𝑃𝑃11,𝑙𝑙
𝑷𝑷𝒍𝒍 = � ⋮
𝑃𝑃𝐾𝐾1,𝑙𝑙

⋯ 𝑃𝑃1𝐾𝐾,𝑙𝑙
⋱
⋮ �.
⋯ 𝑃𝑃𝐾𝐾𝐾𝐾,𝑙𝑙

The rows of 𝑷𝑷𝒍𝒍 satisfy the condition ∑𝐾𝐾
𝑗𝑗=1 𝑃𝑃ℎ𝑗𝑗,𝑙𝑙 = 1. The Markov chain is often assumed

to be time homogenous. In this case, we have𝑷𝑷𝒍𝒍 = 𝑷𝑷 and 𝑃𝑃ℎ𝑗𝑗,𝑙𝑙 = 𝑃𝑃ℎ𝑗𝑗 , which is a constant

of time.

Baseline covariates 𝒁𝒁 are usually linked to the transition probabilities through a

series of polytomous logistic regressions

𝑃𝑃ℎ𝑗𝑗
𝑙𝑙𝑙𝑙𝑙𝑙 � � = 𝛽𝛽ℎ𝑗𝑗,0 + 𝜷𝜷𝑻𝑻𝒉𝒉𝒉𝒉 𝒁𝒁,
𝑃𝑃ℎℎ
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𝑗𝑗 ≠ ℎ.

There are 𝐾𝐾 possible polytomous logistic regressions, one model for each row of the

transition probability matrix. When the model only involves baseline covariates, standard
software such as PROC LOGISTIC and PROC CATMOD (SAS Institute, Inc.; Cary NC)
[28] can be used to fit each logistic model separately.
2.2.2

Continuous-time multi-state model
In a continuous-time multi-state model, the transition process is modeled as a

stochastic process. The longitudinal data are allowed to be unevenly spaced. We can
write the transition probability from state ℎ at time 𝑠𝑠 to state 𝑗𝑗 at time 𝑡𝑡 as
𝑃𝑃ℎ𝑗𝑗 (𝑠𝑠, 𝑡𝑡|𝐻𝐻𝑠𝑠− ) = 𝑃𝑃(𝑋𝑋(𝑡𝑡) = 𝑗𝑗|𝑋𝑋(𝑠𝑠) = ℎ, 𝐻𝐻𝑠𝑠− ) , s < t.

Here, 𝐻𝐻𝑠𝑠− is the history of the process up to time 𝑠𝑠. For a Markov process, the transition

probabilities is independent of the past history before time 𝑠𝑠. In this case, we have
𝑃𝑃ℎ𝑗𝑗 (𝑠𝑠, 𝑡𝑡) = 𝑃𝑃(𝑋𝑋(𝑡𝑡) = 𝑗𝑗|𝑋𝑋(𝑠𝑠) = ℎ ) , s < t.

The transition probabilities can be fully characterized by the corresponding
transition intensities, which have the following definition
𝛼𝛼ℎ𝑗𝑗 (𝑡𝑡) = lim 𝑃𝑃ℎ𝑗𝑗 (𝑡𝑡 + ∆𝑡𝑡, 𝑡𝑡)/∆𝑡𝑡 , 𝑗𝑗 ≠ ℎ.
∆𝑡𝑡→0

Similar to the hazard function in survival models, the transition intensities
measure the instantaneous hazard of transition from the current state ℎ to another state 𝑗𝑗.
For 𝑗𝑗 = ℎ, we have

𝛼𝛼ℎℎ (𝑡𝑡) = − � 𝛼𝛼ℎ𝑗𝑗 (𝑡𝑡).
𝑗𝑗≠ℎ
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Different assumptions can be made about the dependence of the transition
intensities on time. In this study, we focus on time homogenous models. In a time
homogenous model, we have 𝛼𝛼ℎ𝑗𝑗 (𝑡𝑡) = 𝛼𝛼ℎ𝑗𝑗 .

Covariates of interest can be incorporated into the transition intensities using the

Cox proportional hazards regression model, which has the following form
𝛼𝛼ℎ𝑗𝑗 (𝒁𝒁) = 𝛼𝛼ℎ𝑗𝑗,0 𝑒𝑒𝑒𝑒𝑒𝑒�𝜷𝜷𝑻𝑻𝒉𝒉𝒉𝒉 𝒁𝒁� = 𝑒𝑒𝑒𝑒𝑒𝑒�𝛽𝛽ℎ𝑗𝑗,0 + 𝜷𝜷𝑻𝑻𝒉𝒉𝒉𝒉 𝒁𝒁� .

Here, 𝛼𝛼ℎ𝑗𝑗,0 = 𝑒𝑒𝑒𝑒𝑒𝑒�𝛽𝛽ℎ𝑗𝑗,0 � is called the baseline intensity from state ℎ to state 𝑗𝑗.
Write the transition intensity matrix as
𝛼𝛼11 (𝒁𝒁)
𝑸𝑸 = � ⋮
𝛼𝛼𝐾𝐾1 (𝒁𝒁)

and write the transition probability matrix as
𝑷𝑷(𝑠𝑠, 𝑡𝑡) = �

⋯ 𝛼𝛼1𝐾𝐾 (𝒁𝒁)
⋱
⋮ �,
⋯ 𝛼𝛼𝐾𝐾𝐾𝐾 (𝒁𝒁)

𝑃𝑃11 (𝑠𝑠, 𝑡𝑡)
⋮
𝑃𝑃𝐾𝐾1 (𝑠𝑠, 𝑡𝑡)

⋯
⋱
⋯

𝑃𝑃1𝐾𝐾 (𝑠𝑠, 𝑡𝑡)
⋮
�.
𝑃𝑃𝐾𝐾𝐾𝐾 (𝑠𝑠, 𝑡𝑡)

For a time homogenous model, 𝑷𝑷(𝑠𝑠, 𝑡𝑡) can be calculated in terms of the transition
intensity matrix 𝑸𝑸 using the Kolmogorov differential equation [5]
𝑷𝑷(𝑠𝑠, 𝑡𝑡) = 𝑷𝑷(𝑡𝑡 − 𝑠𝑠) = 𝐸𝐸𝐸𝐸𝐸𝐸((𝑡𝑡 − 𝑠𝑠)𝑸𝑸)

Estimation of the model can be done using the maximum likelihood method.
Given an individual has observations at time points ( 𝑡𝑡0 , 𝑡𝑡1 , … , 𝑡𝑡m ) and corresponding
observed states (𝑋𝑋0 , 𝑋𝑋1 , … , 𝑋𝑋𝑚𝑚 ), its likelihood contribution can be calculated as

𝐿𝐿 = 𝑃𝑃(𝑋𝑋0 , 𝑋𝑋1 , … , 𝑋𝑋𝑚𝑚 ) = 𝑃𝑃(𝑋𝑋0 ) × 𝑃𝑃𝑋𝑋0 𝑋𝑋1 ( 𝑡𝑡0 , 𝑡𝑡1 ) × ⋯ × 𝑃𝑃𝑋𝑋𝑚𝑚−1 𝑋𝑋𝑚𝑚 ( 𝑡𝑡𝑚𝑚−1 , 𝑡𝑡𝑚𝑚 ).

Through the transition intensities, we are able to calculate the transition probabilities at
any given time period. Thus, we are able to handle unevenly spaced longitudinal data.
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We can also handle transitions with exact transition times. Death is an important
competing risk in many chronic diseases and is often included in the model. The exact
time of death will be recorded, while the state just before death might be unknown.
Suppose the last state 𝑋𝑋𝑚𝑚 = 𝐾𝐾 is death and 𝑡𝑡m is the time of death. In this case, the

likelihood contribution can be calculated as
𝐿𝐿 = 𝑃𝑃(𝑋𝑋0 , 𝑋𝑋1 , … , 𝑋𝑋𝑚𝑚 )

= 𝑃𝑃(𝑋𝑋0 ) × 𝑃𝑃𝑋𝑋0 𝑋𝑋1 ( 𝑡𝑡0 , 𝑡𝑡1 ) × ⋯ × �� 𝑃𝑃𝑋𝑋𝑚𝑚−1 𝑗𝑗 ( 𝑡𝑡𝑚𝑚−1 , 𝑡𝑡𝑚𝑚 ) 𝛼𝛼𝑗𝑗𝑗𝑗 (𝒁𝒁)�
𝑗𝑗≠𝐾𝐾

2.2.3

Relationship between the two models
Two types of models are constructed under different assumptions about the

response data. The discrete-time MSM assumes the transitions follow a Markov chain.
However, the continuous-time MSM assumes the transitions follow a continuous-time
Markov process. Thus, the covariates coefficients in the two types MSMs have different
interpretations. The discrete-time MSM incorporates covariates into the model through a
series multinomial logit regressions; the corresponding coefficients have the log odds
ratio interpretation. The continuous-time MSM incorporates covariates trough transition
intensity functions by proportional hazard regressions; the corresponding coefficients
have the log hazard ratio interpretation.
The relationship between the two types of models is linked through their one step
transition probabilities. Note that in our notation 𝑷𝑷 is the one step transition probability

for the discrete-time model and 𝑷𝑷(𝑡𝑡 − 𝑠𝑠) is the transition probability matrix from time s
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to time t for the continuous-time model. Suppose the time interval between two
assessments equals one time unit; thus we have 𝑷𝑷 = 𝑷𝑷(1).
2.3

Simulation Study
In chronic disease studies, the collected longitudinal data are often not evenly

spaced. In this section, we conduct simulation studies to compare the performance of the
two types of MSMs under different observation schemes. The comparisons are taken
under three types of observed data:
(1) Evenly spaced data: the time intervals between two consecutive observations
are all equal to 1 year;
(2) Unevenly spaced data 1: the time intervals between two consecutive
observations follow a truncated Normal distribution with mean 1 and standard
deviation 0.5, left truncated at 0.25.
(3) Unevenly spaced data 2: the time intervals between two consecutive
observations follow a Normal distribution with mean 1 and standard deviation
1.5, left truncated at 0.25.
We focus on the one-year transition probability estimates �𝑃𝑃ℎ𝑗𝑗 �. Comparisons are

made by their percent biases (% bias) for the two methods under these three types of
observed data.

Data are generated from a four-state model with state 1 and state 2 representing
two transient states, and state 3 and state 4 representing two absorbing states. The true
model has the following transition intensity matrix:

19

𝛼𝛼11
𝛼𝛼 𝑒𝑒𝑒𝑒𝑒𝑒(𝛽𝛽21 𝑍𝑍)
𝑸𝑸 = � 21,0
0
0

𝛼𝛼12,0 𝑒𝑒𝑒𝑒𝑒𝑒(𝛽𝛽12 𝑍𝑍)
𝛼𝛼22
0
0

𝛼𝛼13,0 𝑒𝑒𝑒𝑒𝑒𝑒(𝛽𝛽13 𝑍𝑍) 𝛼𝛼14,0
𝛼𝛼23,0 𝑒𝑒𝑒𝑒𝑒𝑒(𝛽𝛽23 𝑍𝑍) 𝛼𝛼24,0 � .
0
0
0
0

Here, 𝑍𝑍 is a binary baseline covariate. In our simulation study, 𝑍𝑍 follows a Bernoulli
distribution with probability of 0.4 with value 1. We set the baseline intensities

�𝛼𝛼12,0 , 𝛼𝛼13,0 , 𝛼𝛼14,0 , 𝛼𝛼21,0 , 𝛼𝛼23,0 , 𝛼𝛼24,0 � = (0.25, 0.03, 0.05, 0.2, 0.15, 0.05),

and the regression coefficients

(𝛽𝛽12 , 𝛽𝛽13 , 𝛽𝛽21 , 𝛽𝛽23 ) = (0.5, −0.2, −0.3, 0.15).

For all three observation schemes, each subject has up to 30 observations. If a
patient is still at state 2 or state 3 after 30 years, it will be right censored at year 30. The
exact transition times to state 4 are recorded, while the transition time to state 1, 2, or 3
are all interval censored because of the discrete time observations as we described above.
Simulations are set to 1000 iterations, with each containing 500 subjects. For
simplicity, all subjects start at state 1. All calculations are done by using the “msm”
package [29] in R and the PROC IML [30] and PROC CATMOD [28] procedures in SAS
9.3 system.
Table 2.1 and Table 2.2 list the percent bias of the one year transition probabilities
by discrete-time MSM and by continuous-time MSM respectively. The results show that
the discrete-time MSM and continuous-time MSM work equally well when the data is
evenly spaced. Since the calculation of transition probabilities through the transition
intensities are usually complicated, discrete-time MSM has the computational advantage
over the continuous-time MSM.
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When the collected longitudinal data are unevenly spaced, the discrete-time MSM
will provide biased estimates for the one year transition probabilities. We may observe
that the biases of the estimations of one year transition probabilities increase as the
spacing gets more uneven. For example, the percent bias of the transition probability
estimate from state 1 to state 3 with the covariate 𝑍𝑍 = 1 by the discrete-time Markov

MSM could be as large as 20% in unevenly spaced data with relative less the observation
time interval variation (unevenly spaced data 1 in the tables), and increase to 69% in
unevenly spaced data with relatively larger observation time interval variation (unevenly
spaced data 2 in the tables). For the same case, the percent bias of transition probability
estimate from state 1 to state 3 with the covariate 𝑍𝑍 = 1 by the continuous-time Markov

MSM is only 1.3% in unevenly spaced data 1, and 1.8% in unevenly spaced data 2. Thus,
in those longitudinal chronic disease studies in which the actual visit times deviate from
the planned visit times, with possible skipped visits, continuous-time MSMs are
recommended.
2.4

Application to the Nun Study
In this section, we apply both the discrete-time MSM and continuous-time MSM

to the Nun Study dataset. The models include four states: Not Serious Impairment (NSI),
Global Impairment (GI), Dementia, and Death. The transition flows and frequencies
among these states are shown in Figure 2.1.
A total of 55 subjects were excluded from the study due to missing APOE4
genotype (55 or 8.18%). The final analytic sample used in the study consists of 617
subjects having 3312 observations. At baseline, 440 (71.3%) subjects were in state NSI;
60 (9.7%) subjects were already in state GI and 117 (19.0%) subjects have already
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developed dementia. At the end of the study, there were 74 subjects who survived
without dementia or censored before converting to dementia, 279 subjects who developed
dementia, 264 who died without dementia, and 263 subjects who died with dementia.
Even though the study was designed to conduct cognitive assessments annually,
the actual number of total assessments and the time interval between two consecutive
assessments varied across subjects. The number of assessments ranges from 2 to 12 with
an average of 6 assessments. The time interval between two assessments ranges from
0.01 year to 10 years, with an average of 1.4 ± 0.6 years. Figure 2.2 presents the
histogram of the time intervals between two consecutive assessments up to 4 years.
We considered two risk factors in our four-state model: baseline age and APOE4
(1=at least one ε4 allele, 0= noε4 allele). The baseline ages range from 75.37 to 102.01
with mean 83.45 ± 5.53. In the model, baseline ages were centered at age 75. There are
141 (22.85%) subjects with at least one APOE4 allele. Table 2.3 lists the odds ratios of
these two risk factors estimated by the discrete-time MSM described in Section 2.1. And
Table 2.4 lists the hazard ratios of these two risk factors estimated by the continuous-time
MSM described in Section 2.2. Both models show baseline age has significant effects on
transitions from NSI to GI, Dementia and Death, from GI to Dementia, and from
Dementia to Death; and APOE4 has significant effects on transition from NSI to GI.
The two models differ on the transition probability estimations. Figure 2.3 plots
the estimated transition probabilities from NSI to dementia and from GI to dementia for
an 80-years-old subjects with and without APOE4. The plots indicate that the discretetime model has relatively lower long-term transition probabilities from NSI to dementia
and from GI to dementia than the continuous-time model.
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To see which model fits the data better, we conducted a goodness-of-fit analysis
by using prevalence counts [31]. Figure 2.4 presents the comparison of observed
prevalence and expected prevalence counts from both discrete-time and continuous-time
models. The dot circle line is the observed prevalence counts; the dashed line is the
expected prevalence counts estimated from the discrete-time model; and the solid line is
the expected prevalence counts estimated from the continuous-time model. In general, the
expected prevalence estimated from the continuous-time model is closer to the observed
prevalence than the expected prevalence estimated from the discrete-time model. This
provides some evidence that the continuous-time model fits the data better than then
discrete-time model.
2.5

Discussion
In longitudinal chronic disease studies, the natural development of a chronic

disease is often expressed in terms of distinct states and MSMs are widely used to model
the progression of individuals through these states. Most studies focused on modeling the
true disease progression as a discrete time Markov chain. While Markov chain models
can accommodate the simultaneous analysis of multiple events of interest and inclusion
of competing risks through the states defined in the model, use of Markov chains have
some potential limitations. As it requires the time intervals between two consecutive
assessments are all equal among subjects, and it does not allow unobserved transitions
between two consecutive assessments. In real studies, the data are often unevenly spaced
and multiple unobserved transitions may take place between cycle assessments. A more
general model, continuous-time MSM could be an alternative approach which can
accommodate the evenly spaced data under different types of observation schemes.
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To the best of our knowledge, this research is the first to compare the
performance of the widely used discrete-time multi-state model with the continuous-time
multi-state model for unevenly spaced data. The simulation study compares the one year
transition probability under three types of observed data, one evenly spaced data and two
unevenly spaced data. The results show that when the longitudinal observations are
evenly spaced, both versions of MSMs work equally well. Since the calculation of
transition probabilities through the transition intensities is usually complicated, the
discrete-time MSMs have the computational advantage over the continuous-time version
MSMs. When longitudinal observations are unevenly spaced, the discrete-time MSMs
would be biased. In this case, the continuous-time MSMs are recommended.
In the application of the Nun’s data, the discrete-time model has relative worse
performance compared to the continuous-time model. Both models provided similar
results of the effects of baseline age and APOE4 in the model. However, the estimations
of the transition probabilities are different by the two models. The discrete-time model
has relative lower long-term transition probability estimations from state NSI to dementia
and from state GI to dementia. The average time interval between two consecutive
assessments was 1.4±0.6 years (larger than 1 year assumption of the discrete-time model)
in the Nun’s data, which is one of the reason the discrete-time model underestimates the
long-term transition probabilities from NSI to dementia and from GI to dementia.
In conclusion, discrete-time Markov chain models are useful tools for survival
analysis that allow for more nuanced modeling that is available in most standard time to
event methods. However, most journal readers and reviewers may readily comprehend
the results from discrete-time Markov chain models, but they may lack familiarity with
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the underlying statistical assumptions. If so, they may neglect to challenge investigators
to demonstrate these assumptions are tenable [32]. A continuous time MSM could be an
alternative approach and should have a potential to being used much more by
practitioners, although the lack of knowledge of the available software may be
responsible for its lack of popularity. Given that improper use of Markov models may
result in biased estimation, perhaps some standardization in the reporting of MSM results
and assumption verification is needed.

25

Table 2.1 Percent bias of one year transition probability for each path by the discrete-time
multi-state model under three observation schemes.
Evenly Spaced
Unevenly Spaced
Unevenly Spaced
Data
Data 1
Data 2
Transition
Z=0
Z=1
Z=0
Z=1
Z=0
Z=1
1 to 1
-0.29%
0.22%
0.77%
2.50%
-2.00%
-1.10%
1 to 2
0.40%
-0.42%
-2.00%
-10.00%
-5.50%
-14.00%
1 to 3
-0.74%
1.00%
-1.40%
20.00%
38.00%
69.00%
1 to 4
-0.38%
0.76%
-3.30%
7.00%
19.00%
28.00%
2 to 1
0.27%
-0.39%
-3.10%
-7.90%
-7.20%
-12.00%
2 to 2
-0.18%
0.21%
-0.51%
2.90%
-3.30%
-0.09%
2 to 3
0.45%
-0.45%
3.60%
-5.90%
16.00%
6.60%
2 to 4
0.66%
-0.94%
7.20%
-9.50%
27.00%
5.20%

Table 2.2 Percent bias of one year transition probability for each path by the continuoustime multi-state model under three observation schemes.
Evenly Spaced
Unevenly Spaced
Unevenly Spaced
Data
Data 1
Data 2
Transition
Z=0
Z=1
Z=0
Z=1
Z=0
Z=1
1 to 1
-0.06% -0.31%
-0.01%
0.12%
0.02%
-0.49%
1 to 2
0.42% 0.51%
-0.04%
-0.45%
-0.06%
0.73%
1 to 3
-0.44% 1.50%
0.86%
1.30%
-0.91%
1.80%
1 to 4
-0.23% -0.31%
-0.39%
-0.37%
0.64%
0.54%
2 to 1
0.41% 0.23%
0.55%
0.82%
0.74%
-0.14%
2 to 2
-0.08% 0.03%
-0.27%
-0.17%
-0.27%
0.11%
2 to 3
0.22% -0.08%
0.74%
0.17%
0.62%
-0.48%
2 to 4
-0.72% -0.72%
0.24%
0.30%
0.10%
0.15%
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Table 2.3 Discrete-time MSM results on the Nun’s data
Covariates
Transition Path
Coefficient
Intercept
NSI to GI
-2.9425
NSI to Dementia
-3.9931
NSI to Death
-3.0251
GI to NSI
-1.1615
GI to Dementia
-1.4880
GI to Death
-0.6328
Dementia to Death
-1.3189
Baseline Age
NSI to GI
0.1044
NSI to Dementia
0.1405
NSI to Death
0.0963
GI to NSI
0.0101
GI to Dementia
0.0525
GI to Death
0.0161
Dementia to Death
0.0632
APOE4
NSI to GI
0.5799
NSI to Dementia
0.5064
NSI to Death
0.3976
GI to NSI
-0.6509
GI to Dementia
0.5268
GI to Death
-0.2533
Dementia to Death
0.0417
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Std.Err
0.1512
0.2213
0.1613
0.3001
0.2901
0.2429
0.1677
0.0171
0.0225
0.0186
0.0294
0.0254
0.0235
0.0137
0.1940
0.2831
0.2191
0.4233
0.3066
0.3018
0.1661

P value
<.01
<.01
<.01
<.01
<.01
<.01
<.01
<.01
<.01
<.01
0.73
0.04
0.49
<.01
<.01
0.07
0.07
0.12
0.09
0.40
0.80

Table 2.4 Continuous-time MSM results on the Nun’s data
Covariates
Transition Path
Coefficient
Intercept
NSI to GI
-2.8417
NSI to Dementia
-4.6231
NSI to Death
-3.8646
GI to NSI
-1.7183
GI to Dementia
-1.8899
GI to Death
-1.2368
Dementia to Death
-1.6425
Baseline Age
NSI to GI
0.0882
NSI to Dementia
0.1277
NSI to Death
0.0646
GI to NSI
0.0100
GI to Dementia
0.0375
GI to Death
-0.0215
Dementia to Death
0.0364
APOE4
NSI to GI
0.4447
NSI to Dementia
0.0403
NSI to Death
0.3561
GI to NSI
-0.6053
GI to Dementia
0.4952
GI to Death
-0.5631
Dementia to Death
0.0112
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Std.Err
0.1515
0.3545
0.2856
0.2711
0.2428
0.2364
0.1382
0.0168
0.0360
0.0321
0.0268
0.0183
0.0246
0.0106
0.1968
0.7244
0.3711
0.3994
0.2611
0.3679
0.1331

P value
<.01
<.01
<.01
<.01
<.01
<.01
<.01
<.01
<.01
0.04
0.71
0.04
0.38
<.01
0.02
0.96
0.34
0.13
0.06
0.13
0.93

Figure 2.1 Transition flows among the four states recorded in the Nun’s data

Figure 2.2 Histogram of time intervals between two consecutive assessments.
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Figure 2.3 Transition probabilities from NSI to dementia and from GI to dementia for an
80 years old subject with and without APOE4.
(Solid line: Transition probabilities estimated by the continuous-time model; and
dashed line: Transition probabilities estimated by the discrete-time model.)
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Figure 2.4 Comparison of observed and expected prevalence of the two types of
MSMs. (Dot: observed prevalence; solid line: expected prevalence estimated from
the continuous-time model; and dashed line: expected prevalence estimated from
the discrete-time model.)
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Chapter 3 A Non-homogenous Markov Multi-State Model for interval censored
transient cognitive states with competing risk
3.1

Introduction
Multi-state interval-censored data are usually handled by time homogenous

Markov models (HMM) [33, 34] or piece-wise homogenous models [29]. However, the
assumption of time homogeneity would be inappropriate if the disease process is heavily
dependent on the time scale considered in the model. In non-homogenous Markov
Models (NHMM), the problem of inference with interval-censored data is considerably
more difficult. Transition probabilities can be expressed simply in terms of transition
intensities in a HMM but not in a more general NHMM.
Only a few studies have been carried out regarding NHMM in the presence of
interval-censored data. One of the first such studies was that of Hsien, et al.[35]. They
presented a three-state progressive NHMM with the incorporation of Weibull distribution
and the piecewise exponential model to accommodate non-constant transition rates. Hout,
et al. [8] extended this approach by including the possibility to move directly from the
health state to the death state, namely an “illness-death” model. Hubbard and Zhou [27]
proposed a non-homogenous four-state model with one absorbing state (death) by using
time-transformation. The non-homogenous model is converted to a homogenous model
by transforming the time scale by a specific select transformation function. Selecting the
appropriate transformation function is the key in their model. However, they did not
provide a procedure for selecting the appropriate transformation function, and it is
dependent on researcher’s personal judgment to choose which transformation function to
use.
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In this chapter, we develop a four-state NHMM that allows for interval-censored
data as well as the possible unobserved transitions caused by discrete-time observations.
The research is motivated by the Biologically Resilient Adults in Neurological Studies
(BRAiNS). BRAiNS is a longitudinal study investigating cognitive ability in the older
population. We aim to identify and evaluate the effects of the risk factors on the transition
among different cognitive states.
The rest of this chapter is structured as follows. In Section 3.2, we describe the
data set which motivated this research. In Section 3.3, the four state continuous time
Markov model with Weibull assumption is defined. In Section 3.4, a simulation study is
conducted to check whether the Weibull assumption is robust. Section 3.5 applies this
method to the BRAiNS data. At the last section, we discuss the proposed method and lay
down some possible future directions.
3.2

Data
The BRAiNS is a longitudinal cohort of 1,030 older participants at the University

of Kentucky’s Alzheimer’s Disease Center (UK ADC) [36]. Participants consent to
extensive annual cognitive and clinical examinations as well as brain donation upon
death. Subjects included in the current study (n=531) were assessed at least two times and
all subjects were cognitively intact at study entry.
Annual cognitive assessments are administered to each participant and used to
classify them into one of three cognitive states: normal, clinical MCI, or dementia. The
diagnosis of clinical MCI is based on a consensus team review by the examining
physician, neuropsychologist, and the clinical research assistant who administered the
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cognitive assessment. A dementia classification results from a clinical consensus
diagnosis of dementia.
Mortality has been shown to be an important competing risk for MCI and
dementia [22]. Thus, we would also include the state death into our model. Participants
were evaluated cognitively and during follow up may die or transition to clinical MCI or
dementia. All transitions are unidirectional since it is assumed that once a participant
meets the criteria for a diagnosis of clinical MCI (or dementia) he/she does not return to
the normal state. In the application to these participants from the BRAiNS cohort, 19
subjects made an apparent reverse transition from clinical MCI to normal, but as
discussed in Abner, et al.[20], these were determined to be the result of either underlying
medical comorbidities that influenced cognition or diagnostic misclassification; the errant
diagnoses were recoded. The exact times of transitions into MCI or dementia are interval
censored because of the irregularity of the observation process, while the time of entry
into the study and the time of death are known exactly.
3.3
3.3.1

Methodology
The non-homogeneous Markov multi-state model
We consider a four-state model with two transient states and two absorbing states.

State 1, normal cognition, and State 2, mild cognitive impairment (MCI), are transient
states. State 3, dementia, and State 4, death without dementia, are two absorbing states.
See Figure 3.1 for the transition diagram.
Let 𝑃𝑃ℎ𝑗𝑗 (𝑠𝑠, 𝑡𝑡) be the transition probability from state ℎ at age 𝑠𝑠 to state 𝑗𝑗 at

age 𝑡𝑡 (𝑡𝑡 > 𝑠𝑠). Let 𝛼𝛼ℎ𝑗𝑗 (𝑡𝑡) be the transition intensity from state ℎ to state 𝑗𝑗 at age 𝑡𝑡.
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Denote 𝑸𝑸(𝑡𝑡) the transition intensity matrix with the (ℎ, 𝑗𝑗)th being 𝛼𝛼ℎ𝑗𝑗 (𝑡𝑡). Since the
model is irreversible, and State 3 and State 4 are absorbing states, we have

Here,

and

𝛼𝛼11 (𝑡𝑡)
𝑸𝑸(𝑡𝑡) = � 0
0
0

𝛼𝛼12 (𝑡𝑡) 𝛼𝛼13 (𝑡𝑡) 𝛼𝛼14 (𝑡𝑡)
𝛼𝛼22 (𝑡𝑡) 𝛼𝛼23 (𝑡𝑡) 𝛼𝛼24 (𝑡𝑡)� .
0
0
0
0
0
0

𝛼𝛼11 (𝑡𝑡) = −�𝛼𝛼12 (𝑡𝑡) + 𝛼𝛼13 (𝑡𝑡) + 𝛼𝛼14 (𝑡𝑡)�
𝛼𝛼22 (𝑡𝑡) = −�𝛼𝛼23 (𝑡𝑡) + 𝛼𝛼24 (𝑡𝑡)�.

Since age is the major risk factor of MCI, dementia and death [2, 22], and we are
mostly interested in age-specific incidence and age-specific mortality, we consider a nonhomogeneous Markov model where the intensities depend on age, and chose the actual
age of participants as the time scale, 𝑡𝑡, in the form of transition intensities, rather than the
calendar year or years since enrolment.
3.3.2

Proportional hazard regression with Weibull baseline
Other risk factors besides age can also be added to the model through proportional

hazards regressions, which has the following form
𝛼𝛼ℎ𝑗𝑗 (𝑡𝑡|𝒁𝒁) = 𝛼𝛼ℎ𝑗𝑗,0 (𝑡𝑡 − 𝐴𝐴0 ) 𝑒𝑒𝑒𝑒𝑒𝑒�𝜷𝜷𝑻𝑻𝒉𝒉𝒉𝒉 𝒁𝒁� ,

𝑡𝑡 ≥ 𝐴𝐴0

Here, 𝒁𝒁 is a vector of covariates, such as gender, education level, diabetes, smoking, etc.,
𝛼𝛼ℎ𝑗𝑗,0 (𝑡𝑡) is the baseline intensity for transition from state ℎ to state 𝑗𝑗, 𝐴𝐴0 is the start time

of the process, and the covariates coefficients 𝜷𝜷𝒉𝒉𝒉𝒉 are transition specific; in other words,
the coefficients for the same covariates on different transition paths are specific to those
paths.
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We assume the baseline intensities follow the Weibull hazard form with scale
parameter 𝜆𝜆ℎ𝑗𝑗 = 𝑒𝑒𝑒𝑒𝑒𝑒�𝛽𝛽ℎ𝑗𝑗,0 � and shape parameter 𝜅𝜅ℎ𝑗𝑗 to accommodate the nonhomogeneous property. We have

𝛼𝛼ℎ𝑗𝑗0 (𝑡𝑡) = 𝜆𝜆ℎ𝑗𝑗 𝜅𝜅ℎ𝑗𝑗 𝑡𝑡 𝜅𝜅ℎ𝑗𝑗−1 = 𝜅𝜅ℎ𝑗𝑗 𝑡𝑡 𝜅𝜅ℎ𝑗𝑗−1 𝑒𝑒𝑒𝑒𝑒𝑒�𝛽𝛽ℎ𝑗𝑗,0 �,

ℎ = 1,2; 𝑗𝑗 = ℎ + 1, … ,4.

Using the Weibull baseline hazards enable us to model a variety shapes of intensity

forms. For example, the baseline intensity increases with age when 𝜅𝜅ℎ𝑗𝑗 > 1; the baseline

intensity deceases with age when 0 < 𝜅𝜅ℎ𝑗𝑗 < 1; and the baseline intensity is time

homogeneous when 𝜅𝜅ℎ𝑗𝑗 = 1.
3.3.3

Observation Schemes
Because the study design and the way the cognitive states were determined, the

data is left truncated, right censored and interval-censored. First, the data is left truncated.
Subjects included in the study are all at normal cognition state at their baseline, and we
excluded these subjects who were already in MCI or dementia state from enrolling. Thus
the data is left truncated [1]. Second, the data are also right censored. The right censoring
occurs when participants drop out of the study before they develop dementia or die, or
remain normal cognition or MCI at the end of the study. Since the cognitive states of
participants are only assessed at discrete time points, the exact transition time into state
MCI and dementia is unknown. The transition times are only known between two
consecutive assessed time points where an transition were observed, thus the data is also
interval-censored.
The discrete-time observation scheme not only caused interval-censoring, but also
lead to unobserved transitions. For example, a participant who is diagnosed with
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dementia from normal cognition directly, it is unknown whether the participant has made
the transition into MCI first or not. Similarly, if a subject dies with normal cognition at
the latest assessment, it is not known whether the subject has made a transition into MCI
in the interval between those events. Thus, it is possible that some transitions might not
be observed and recorded in the data.
Although the cognition assessments are made at discrete time points, the exact
time of death can be retrieved and is recorded in the data. Since there is no cognition
assessment at the time of death, the cognitive state just before death is unknown.
There are total 6 possible observed transition paths for a subject, as shown in
Figure 3.2. In the BRAiNS data, we set the start time of the process 𝐴𝐴𝑖𝑖,0 = 60 for all

participants since they were all at least 60 years old at their baseline. Also let 𝐴𝐴𝑖𝑖,𝑏𝑏 be the

age at baseline for participant 𝑖𝑖; 𝐴𝐴𝑖𝑖,1𝑁𝑁 be the age at the last time participant 𝑖𝑖 is observed

in state 1 (normal); 𝐴𝐴𝑖𝑖,20 be the age at the first time the participant is observed in state 2

(MCI); 𝐴𝐴𝑖𝑖,2𝑁𝑁 be the age at the last time the participant is observed in state 2; 𝐴𝐴𝑖𝑖,𝑁𝑁 be the
age at the last time participant 𝑖𝑖 had an observation. We also write 𝑈𝑈𝑖𝑖,ℎ𝑗𝑗 to be the age at

the time participant 𝑖𝑖 transitions from state ℎ to state 𝑗𝑗, for example, 𝑈𝑈𝑖𝑖,12 is the age at the
time participant transitions from state 1 to state 2 and 𝑈𝑈𝑖𝑖,23 is the age at the time

participant transitions from state 2 to state 3. All of 𝑈𝑈𝑖𝑖,12 , 𝑈𝑈𝑖𝑖,13 and 𝑈𝑈𝑖𝑖,23 are interval

censored. The transition times to death, which are 𝑈𝑈𝑖𝑖,14 and 𝑈𝑈𝑖𝑖,24 , are known exactly. In
our case we have 𝑈𝑈𝑖𝑖,14 = 𝐴𝐴𝑖𝑖,𝑁𝑁 or 𝑈𝑈𝑖𝑖,24 = 𝐴𝐴𝑖𝑖,𝑁𝑁 if the last state recorded is death.
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3.3.4

Likelihood
Before we construct the likelihood for the model, we denote two transition

probabilities that will help us write the likelihood function. First, we have
𝑃𝑃11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝑡𝑡� = 𝑒𝑒𝑒𝑒𝑒𝑒 �− �Λ 𝑖𝑖,1 (𝑡𝑡) − Λ 𝑖𝑖,1 �𝐴𝐴𝑖𝑖,𝑏𝑏 ���.

Here, Λ 𝑖𝑖,1 (𝑡𝑡) is the cumulative hazard function of subject 𝑖𝑖 for leaving state 1 and it has

the form:

Λ 𝑖𝑖,1 (𝑡𝑡) =

𝑡𝑡

� �𝛼𝛼12 (𝑢𝑢) + 𝛼𝛼13 (𝑢𝑢) + 𝛼𝛼14 (𝑢𝑢)�𝑑𝑑𝑑𝑑

𝐴𝐴𝑖𝑖,0 =60

𝑇𝑇
𝑇𝑇
= (𝑡𝑡 − 60)𝜅𝜅12 𝑒𝑒𝑒𝑒𝑒𝑒�𝛽𝛽12,0 + 𝜷𝜷12
𝒁𝒁� + (𝑡𝑡 − 60)𝜅𝜅13 𝑒𝑒𝑒𝑒𝑒𝑒�𝛽𝛽13,0 + 𝜷𝜷13
𝒁𝒁�

We also have

𝑇𝑇
+ (𝑡𝑡 − 60)𝜅𝜅14 𝑒𝑒𝑒𝑒𝑒𝑒�𝛽𝛽14,0 + 𝜷𝜷14
𝒁𝒁�

𝑃𝑃22 (𝑠𝑠, 𝑡𝑡) = 𝑒𝑒𝑒𝑒𝑒𝑒 �− �Λ 𝑖𝑖,2 (𝑡𝑡) − Λ 𝑖𝑖,2 (𝑠𝑠)�� .

Here,
Λ 𝑖𝑖,2 (𝑡𝑡) =

𝑡𝑡

� �𝛼𝛼23 (𝑢𝑢) + 𝛼𝛼24 (𝑢𝑢)�

𝐴𝐴𝑖𝑖,0 =60

= (𝑡𝑡 − 60)𝜅𝜅23 𝑒𝑒𝑒𝑒𝑒𝑒�𝛽𝛽23,0 + 𝜷𝜷𝑇𝑇23 𝒁𝒁� + (𝑡𝑡 − 60)𝜅𝜅24 𝑒𝑒𝑒𝑒𝑒𝑒�𝛽𝛽24,0 + 𝜷𝜷𝑇𝑇24 𝒁𝒁�

We will discuss the likelihood construction by each of the six paths as shown in Figure
3.2 .
Path (1): the participant has no transition during the study and is stay in state 1
(normal) at the end of study. In this case, the likelihood contribution for this participant
would be
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𝐿𝐿𝑖𝑖,1 = 𝑃𝑃11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝐴𝐴𝑖𝑖,𝑁𝑁 � = 𝑒𝑒𝑒𝑒𝑒𝑒 �− �Λ 𝑖𝑖,1 �𝐴𝐴𝑖𝑖,𝑁𝑁 � − Λ 𝑖𝑖,1 �𝐴𝐴𝑖𝑖,𝑏𝑏 ���.
Path (2): the participant has one observed transition from state normal to state
MCI and stays in state MCI at the end of study. In this case, we have
𝐿𝐿𝑖𝑖,2 = 𝑃𝑃�𝑋𝑋�𝐴𝐴𝑖𝑖,1𝑁𝑁 � = 1, 𝑋𝑋�𝐴𝐴𝑖𝑖,20 � = 2, 𝑋𝑋�𝐴𝐴𝑖𝑖,𝑁𝑁 � = 2 |𝑋𝑋�𝐴𝐴𝑖𝑖,𝑏𝑏 � = 1�
𝐴𝐴𝑖𝑖,20

= � 𝑃𝑃�𝑋𝑋�𝑈𝑈𝑖𝑖,12 −� = 1|𝑋𝑋�𝐴𝐴𝑖𝑖,𝑏𝑏 � = 1�𝛼𝛼12 �𝑈𝑈𝑖𝑖,12 �𝑃𝑃�𝑋𝑋�𝐴𝐴𝑖𝑖,𝑁𝑁 � = 2|𝑋𝑋�𝑈𝑈𝑖𝑖,12 � = 2� 𝑑𝑑𝑈𝑈𝑖𝑖,12
𝐴𝐴𝑖𝑖,1𝑁𝑁
𝐴𝐴𝑖𝑖,20

= � 𝑃𝑃11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝑈𝑈𝑖𝑖,12 �𝛼𝛼12 �𝑈𝑈𝑖𝑖,12 �𝑃𝑃22 �𝑈𝑈𝑖𝑖,12 , 𝐴𝐴𝑖𝑖,𝑁𝑁 � 𝑑𝑑𝑈𝑈𝑖𝑖,12
𝐴𝐴𝑖𝑖,1𝑁𝑁

Path (3): the patient has one observed transition from normal to state dementia. In
this case, because of the interval-censoring, there could be two possible true paths; we
need to take into account all the information available in such cases of incomplete data.
Scenario 1, the subject might have one transition from state normal directly to state
dementia at time 𝑈𝑈𝑖𝑖,13 . Scenario 2, the subject might have two transitions, first transition
from state normal to state MCI at time 𝑈𝑈𝑖𝑖,12 then transition from state MCI to state

dementia at time 𝑈𝑈𝑖𝑖,23 . Thus, the likelihood of this path has two parts:
𝐿𝐿𝑖𝑖,3 = 𝑃𝑃�𝑋𝑋�𝐴𝐴𝑖𝑖,1𝑁𝑁 � = 1, 𝑋𝑋�𝐴𝐴𝑖𝑖,𝑁𝑁 � = 3|𝑋𝑋�𝐴𝐴𝑖𝑖,𝑏𝑏 � = 1�
𝐴𝐴𝑖𝑖,𝑁𝑁

= � 𝑝𝑝11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝑈𝑈𝑖𝑖,13 �𝛼𝛼13 �𝑈𝑈𝑖𝑖,13 � 𝑑𝑑𝑈𝑈𝑖𝑖,13
𝐴𝐴𝑖𝑖,1𝑁𝑁
𝐴𝐴𝑖𝑖,𝑁𝑁 𝐴𝐴𝑖𝑖,𝑁𝑁

+ �

� 𝑝𝑝11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝑈𝑈𝑖𝑖,12 �𝛼𝛼12 �𝑈𝑈𝑖𝑖,12 �𝑝𝑝22 �𝑈𝑈𝑖𝑖,12 , 𝑈𝑈𝑖𝑖,23 �𝛼𝛼23 �𝑈𝑈𝑖𝑖,23 �𝑑𝑑𝑈𝑈𝑖𝑖,12 𝑑𝑑𝑈𝑈𝑖𝑖,23

𝐴𝐴𝑖𝑖,1𝑁𝑁 𝑈𝑈𝑖𝑖,12

Path (4): subject 𝑖𝑖 has one observed transition from state normal to death without

dementia. Similar in Path (3), there could be two possible scenarios. The subject might
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have just one transition from state 1 directly to state 4 at time 𝐴𝐴𝑖𝑖,𝑁𝑁 ; or it might have two

transitions, first from state normal to state MCI at time 𝑈𝑈𝑖𝑖,12 then transition from state
MCI to death at time 𝐴𝐴𝑖𝑖,𝑁𝑁 . Note that in the BRAiNS data the exact age of death is

recorded but the state just before death is unknown except dementia. Thus the subject
might be at either state normal or state MCI before death. The likelihood for this path can
be calculated as follows:
𝐿𝐿𝑖𝑖,4 = 𝑃𝑃�𝑋𝑋�𝐴𝐴𝑖𝑖,1𝑁𝑁 � = 1, 𝑋𝑋�𝐴𝐴𝑖𝑖,𝑁𝑁 � = 4, 𝑈𝑈𝑖𝑖,14 = 𝐴𝐴𝑖𝑖,𝑁𝑁 |𝑋𝑋�𝐴𝐴𝑖𝑖,𝑏𝑏 � = 1�
= 𝑝𝑝11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝑈𝑈𝑖𝑖,14 �𝛼𝛼14 �𝑈𝑈𝑖𝑖,14 �
𝐴𝐴𝑖𝑖,𝑁𝑁

+ � 𝑝𝑝11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝑈𝑈𝑖𝑖,12 �𝛼𝛼12 �𝑈𝑈𝑖𝑖,12 �𝑝𝑝22 �𝑈𝑈𝑖𝑖,12 , 𝐴𝐴𝑖𝑖,𝑁𝑁 �𝛼𝛼24 �𝑈𝑈𝑖𝑖,24 |𝑈𝑈𝑖𝑖,12 �𝑑𝑑𝑈𝑈𝑖𝑖,12
𝐴𝐴𝑖𝑖,1𝑁𝑁

Path (5): subject 𝑖𝑖 has two observed transitions, first transition from state normal

to state MCI at time 𝑈𝑈𝑖𝑖,12 �𝐴𝐴𝑖𝑖,1𝑁𝑁 < 𝑈𝑈𝑖𝑖,12 ≤ 𝐴𝐴𝑖𝑖,20 � and then from state MCI to state

dementia at time 𝑈𝑈𝑖𝑖,23 �𝐴𝐴𝑖𝑖,2𝑁𝑁 < 𝑈𝑈𝑖𝑖,23 ≤ 𝐴𝐴𝑖𝑖,𝑁𝑁 �. In this case we have

𝐿𝐿𝑖𝑖,5 = 𝑃𝑃�𝑋𝑋�𝐴𝐴𝑖𝑖,1𝑁𝑁 � = 1, 𝑋𝑋�𝐴𝐴𝑖𝑖,20 � = 2, 𝑋𝑋�𝐴𝐴𝑖𝑖,2𝑁𝑁 � = 2, 𝑋𝑋�𝐴𝐴𝑖𝑖,𝑁𝑁 � = 3 |𝑋𝑋�𝐴𝐴𝑖𝑖,𝑏𝑏 � = 1�
𝐴𝐴𝑖𝑖,20

𝐴𝐴𝑖𝑖,𝑁𝑁

= � � � 𝑝𝑝11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝑈𝑈𝑖𝑖,12 �𝛼𝛼12 �𝑈𝑈𝑖𝑖,12 �𝑝𝑝22 �𝑈𝑈𝑖𝑖,12 , 𝑈𝑈𝑖𝑖,23 �𝛼𝛼23 �𝑈𝑈𝑖𝑖,23 �𝑑𝑑𝑈𝑈𝑖𝑖,23 � 𝑑𝑑𝑈𝑈𝑖𝑖,12
𝐴𝐴𝑖𝑖,1𝑁𝑁

𝐴𝐴𝑖𝑖,2𝑁𝑁

Path (6): subject 𝑖𝑖 has two observed transitions, the first is from state normal to

state MCI at time 𝑈𝑈𝑖𝑖,12 �𝐴𝐴𝑖𝑖,1𝑁𝑁 < 𝑈𝑈𝑖𝑖,12 ≤ 𝐴𝐴𝑖𝑖,20 � and the second is from state MCI to state

death at time 𝐴𝐴𝑖𝑖,𝑁𝑁 . In this case we have

𝐿𝐿𝑖𝑖,6 = 𝑃𝑃�𝑋𝑋�𝐴𝐴𝑖𝑖,1𝑁𝑁 � = 1, 𝑋𝑋�𝐴𝐴𝑖𝑖,20 � = 2, 𝑋𝑋�𝐴𝐴𝑖𝑖,𝑁𝑁 −� = 2 , 𝑋𝑋�𝐴𝐴𝑖𝑖,𝑁𝑁 � = 4|𝑋𝑋�𝐴𝐴𝑖𝑖,𝑏𝑏 � = 1�
𝐴𝐴𝑖𝑖,20

= � 𝑝𝑝11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝑈𝑈𝑖𝑖,12 �𝛼𝛼12 �𝑈𝑈𝑖𝑖,12 �𝑝𝑝22 �𝑈𝑈𝑖𝑖,12 , 𝐴𝐴𝑖𝑖,𝑁𝑁 �𝛼𝛼24 �𝐴𝐴𝑖𝑖,𝑁𝑁 � 𝑑𝑑𝑈𝑈𝑖𝑖,12
𝐴𝐴𝑖𝑖,1𝑁𝑁
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3.3.5

Parameter estimation
Since there are no closed forms for likelihood, the trapezoidal rule is used to

approximate the integrals to calculate the transition probabilities in terms of transition
intensities. The parameter estimation is implemented by maximizing the conditional loglikelihood. In particular, all the calculations are conducted in SAS PROC IML procedure
[30]. The log likelihood function can be maximized by the Newton-Raphson Method.
The Hessian matrix of the log likelihood function could be approximated by the finitedifferences method, and its inverse yields the estimated covariance matrix of the
parameters.
3.4

Simulation Study
The main purpose of the simulation study is to examine the sensitivity of the

MLEs of the beta estimates in Equation (1) and (2) to the violation of the Weibull
assumption on the baseline transition intensities. The goal is to quantify how the different
true underlying baseline transition intensities affects the covariate coefficient estimates
using the Weibull baseline intensities in the model. The criteria are bias and mean square
errors of the MLEs of the covariate coefficients.
Data are generated from a model with the following transition intensity matrix
𝛼𝛼11 (𝑡𝑡) 𝛼𝛼12,0 (𝑡𝑡)𝑒𝑒𝑒𝑒𝑒𝑒(𝛽𝛽12 𝑍𝑍) 𝛼𝛼13,0 (𝑡𝑡)𝑒𝑒𝑒𝑒𝑒𝑒(𝛽𝛽13 𝑍𝑍)
𝛼𝛼22 (𝑡𝑡)
𝑒𝑒𝑒𝑒𝑒𝑒�𝛽𝛽23,0 �
𝑸𝑸(𝑡𝑡) = � 0
0
0
0
0
0
0

𝛼𝛼14,0 (𝑡𝑡)𝑒𝑒𝑒𝑒𝑒𝑒(𝛽𝛽14 𝑍𝑍)
𝑒𝑒𝑒𝑒𝑒𝑒�𝛽𝛽24,0 �
0
0

Here, 𝑍𝑍 is a binary covariate distributed as Bernoulli (0.5) and (𝛽𝛽12 , 𝛽𝛽13 , 𝛽𝛽14 ) are the

�.

corresponding coefficients. We set the true values of the coefficients(𝛽𝛽12 , 𝛽𝛽13 , 𝛽𝛽14 ) =
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(2.0, 1.5, 0). For the baseline intensities 𝛼𝛼12,0 (𝑡𝑡), 𝛼𝛼13,0 (𝑡𝑡), and 𝛼𝛼14,0 (𝑡𝑡), we consider three
different forms:

𝐸𝐸
E
E
E
(1) Exponential: 𝛼𝛼1𝑗𝑗,0 (𝑡𝑡) = 𝑒𝑒𝑒𝑒𝑒𝑒(𝛽𝛽1𝑗𝑗,0
) , 𝑗𝑗 = 2, 3, 4. We �𝛽𝛽12,0
, 𝛽𝛽13,0
, 𝛽𝛽14,0
�=

(−4.2, −4.3, −4) for the true model.

𝑊𝑊
(2) Weibull: 𝛼𝛼1𝑗𝑗,0 (𝑡𝑡) = 𝜆𝜆1𝑗𝑗 𝜅𝜅1𝑗𝑗 𝑡𝑡 𝜅𝜅1𝑗𝑗 = 𝑒𝑒𝑒𝑒𝑒𝑒(𝛽𝛽1𝑗𝑗,0
)𝜅𝜅1𝑗𝑗 𝑡𝑡 𝜅𝜅1𝑗𝑗−1 , 𝑗𝑗 = 2, 3, 4. We

W
W
W
, 𝛽𝛽13,0
, 𝛽𝛽14,0
� = (−6.5, −6.7, −6) and (κ12 , κ13 , κ14 ) = (1.9, 2, 2.1).
set �𝛽𝛽12,0

𝐺𝐺
(3) Gompertz: 𝛼𝛼1𝑗𝑗,0 (𝑡𝑡) = 𝛿𝛿1𝑗𝑗 𝑒𝑒𝑒𝑒𝑒𝑒�𝛾𝛾1𝑗𝑗 𝑡𝑡� = 𝑒𝑒𝑒𝑒 𝑝𝑝�𝛽𝛽1𝑗𝑗,0
+ 𝛾𝛾1𝑗𝑗 𝑡𝑡� , 𝑗𝑗 = 2, 3, 4.
G
G
G
Here, �𝛽𝛽12,0
, 𝛽𝛽13,0
, 𝛽𝛽14,0
� = (−8.3, −8.6, −8.1) and (γ12 , γ13 , γ14 ) =

(0.2, 0.22, 0.26).

To simplify, we set the transition intensities from MCI to dementia and death to

be time-homogenous. We set �𝛽𝛽23,0 , 𝛽𝛽24,0 � = (−1.5, −2.0) in the true model. Choice of

the model parameters is made to come as close to those estimated from the real dataset of
the next section without producing simulations that lead to non-estimable parameters, i.e.
the likelihood function fails to converge.
The processes are annually observed starting from State 1 (Normal cognition),
with up to 25 follow-up waves. Latent failure time method [37, 38] is used to simulate the
multi-state data. Simulations were set to have 1000 iterations, with each containing either
300 or 500 subjects. All simulations are done using the IML procedure [30] in SAS
system. The results are presented in Table 3.1 Simulation results of covariate effects for
sample sizes 300 and 500.
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As expected, increasing the sample size improves the estimates in terms of
reducing mean squared error (MSE) and increasing 95% confidence coverage rates. The
biases are reduced considerably when the sample size is increased.
The simulation results also show that the proposed model using Weibull baseline
intensities provides good estimates of the covariate coefficients even in cases where the
true baseline intensities are not Weibull. For all the three intensity forms considered in
this study, the bias and mean square error (MSE) of the estimated effects are all relatively
small. The nominal 95% confidence coverage rates are all close to 95%, except the
91.36% for the Exponential form and 91.75% for the Gompertz form for sample size 300.
3.5

Application to the BRAiNS Study
Subjects included in the current study (n=531) were assessed at least two times

and comprise those included in a previous report [24]. All subjects were cognitively
normal at study entry. The mean baseline age of these participants was 72.6 ± 7.5 years.
The mean number of cognitive assessments for the cohort was 10.3 ± 4.1. During this
follow-up period participants made transitions into MCI and or dementia, while many
others died before such transitions.
The frequency of each type of transition is provided in Table 3.2. Note that over
one-third of the subjects (35.6%) are still at risk for a serious cognitive impairment, while
another third (35.8%) died before converting to a clinical MCI or dementia state. Another
19 subjects with MCI (3.6%) died before converting to dementia. Also, 105 (19.8%) of
the participants transitioned to clinical MCI during follow-up, and 31 of these remain at
risk for a dementia or death. Finally, 88 participants (16.6%) developed dementia during
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follow-up, with 52 of these transitioning directly from normal to dementia between
successive cognitive assessments.
Risk factors of interest here include APOE4 (Apolipoprotein E-4 allele) status,
female gender, and low education (coded as 12 years or less, or more than 12 years). The
subjects have an average of 16.0±2.4 years of education. About 63.1% of the patients are
female and about 30.4% have at least one APOE E-4 allele.
We applied the proposed Weibull model, as well as a time-homogenous model,
and a piecewise-constant model to the BRAiNS data for comparisons. Time-homogenous
model and piecewise-constant model have been discussed in detail by Jackson [29]. Since
all participants were older than 60 years old at baseline, the time scale used in the
Weibull model is the participant’s age minus 60. In the piecewise-constant model, we
divided the age into three periods, below 75, between 75 and 90, and above 90.
Figure 3.3 presents the baseline transition intensities estimated from three models.
Solid line represents the intensity curves estimated by the proposed Weibull model.
Dotted horizontal lines are estimated from the time-homogenous model, and the dash
stepwise lines are from the piecewise-constant model. Here we could see both piecewiseconstant model and Weibull model show that the transition intensities increase as
participants get older.
Table 3.3 lists the hazard ratios and the corresponding 95% confidence interval
(95% C.I.) for each covariate on each of the 5 transition paths by the three models
mentioned above. The results of the hazard ratio estimates are close among these three
models. Having at least one APOE4 (versus no APOE4) significantly increases the
hazard rate for the transition from Normal to MCI, and cognitively normal females have
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lower hazard of death than males. The proposed Weibull model also shows that having
APOE4 would also increase the hazard ratio of transition from normal cognitive directly
to dementia, which is consistent with the previous studies [2, 20, 22]. While, the timehomogenous model and piecewise-constant model failed to indicate the effect of APOE4
on transition from normal cognitive directly to dementia. The Akaike information
criterion (AIC) statistics also show that the proposed Weibull model has the best fit
among the three models, while the time-homogenous model has the worst fit. This further
verifies that it is unrealistic to assume the time homogenous transition intensities in
practice.
3.6

Discussion
Continuous-time multi-state models are useful in analyzing longitudinal event

data. The regression models are simple and intuitive. All the characteristics of disease
progression process could be modeled through the regression of intensity functions. The
coefficients of the covariates have a similar log hazard ratio explanation as in survival
models. Interval-censored data can be easily incorporated in the model, and it allows
equally spaced longitudinal data in which the time interval between two consecutive
longitudinal records varies.
We have presented non-homogeneous Markov models with incorporation of
Weibull distribution to analyze multi-state longitudinal data. Our Weibull assumption
allows us to have non-homogenous hazards, which is more appropriate for most
applications than the widely used homogenous model. Unlike many other nonhomogenous models, we are still able to construct the exact likelihood function through
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our unique model structure, combining Weibull type non-homogenous and homogenous
hazards.
Another advantage of our continuous Weibull model is that it allows us to fit both
right censored and interval-censored data easily. In practice the mixed discrete and
continuous pattern of observational data is very common in chronic disease studies.
Patients are scheduled to visit the hospital at some pre-specified time points, so the exact
transition times are interval-censored. In most cases, the death time is known exactly, but
the state just before the death is unknown. Our continuous Weibull model works well for
both situations.
One limitation of the proposed model is that the likelihood of our model does not
have a closed form, which is needed to calculate the integrals. Multiple integrations were
involved in the likelihood construction. The use of numerical integration solves our
problem, but it reduces the estimation speed of our program, since hundreds of iterations
are needed for each integration calculation. A faster and more reliable numerical
integration method might help.
One possible avenue for future work is verification of the model assumptions,
such as the Markov assumption for transition intensities and the proportional hazards
assumption on covariate effects. A Semi-Markov Model might be a possibility if the
Markov assumption is violated.
In conclusion, exponential regression Markov models with incorporation of the
Weibull distribution were developed to a four state model to model the effects of
covariates on the natural history of chronic disease with dispensing constant hazard
assumption and with necessity for data on interval and right censored cases. In addition to
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Alzheimer disease, our non-homogenous Markov model with Weibull assumption can be
easily applied to data for other chronic disease with or without interval cases.
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Table 3.1 Simulation results of covariate effects for sample sizes 300 and 500
N
True Baseline
Coefficient (True value)
Bias
MSE
95% CR
300 Exponential
-0.007
0.075
91.4%
𝛽𝛽12 (2.0)
0.020
0.082
93.9%
𝛽𝛽13 (1.5)
(0.0)
-0.006
0.144
95.5%
𝛽𝛽14
Weibull
0.034
0.076
94.0%
𝛽𝛽12 (2.0)
(1.5)
0.030
0.070
95.0%
𝛽𝛽13
-0.020
0.066
95.6%
𝛽𝛽14 (0.0)
Gompertz
(2.0)
-0.089
0.104
91.8%
𝛽𝛽12
-0.039
0.099
93.0%
𝛽𝛽13 (1.5)
-0.055
0.060
95.0%
𝛽𝛽14 (0.0)
500 Exponential
-0.005
0.043
94.4%
𝛽𝛽12 (2.0)
0.007
0.046
94.0%
𝛽𝛽13 (1.5)
-0.001
0.085
96.7%
𝛽𝛽14 (0.0)
Weibull
0.015
0.038
96.5%
𝛽𝛽12 (2.0)
-0.004
0.044
95.5%
𝛽𝛽13 (1.5)
0.006
0.036
96.3%
𝛽𝛽14 (0.0)
Gompertz
-0.083
0.062
93.3%
𝛽𝛽12 (2.0)
-0.065
0.061
95.0%
𝛽𝛽13 (1.5)
-0.055
0.032
95.8%
𝛽𝛽14 (0.0)
Note: N--number of subjects, MSE--mean square error, 95% CP--95% confidence
coverage rate.

Table 3.2 Observed transition frequency of each transition type
Transition Type
Frequency
Percent %
Normal → Normal
184
35.65
Normal → MCI
52
9.79
Normal → Dementia
19
3.58
Normal → Death
190
35.78
Normal → MCI → MCI
31
5.84
Normal → MCI → Dementia
36
6.78
Normal → MCI → Death
19
3.58
Total
531
100
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Table 3.3 Hazard Ratio estimates of each covariate by three models
Hazard Ratio (95% C.I.)
Time
Risk Factor Path
Piece-wise constant
Weibull
homogeneous
APOE4
1->2
1.73 (1.14, 2.62)
1.90 (1.25, 2.87)
1.90 (1.26, 2.85 )
1->3
1.75 (0.80, 3.85)
1.98 (0.90, 4.37)
2.03 (1.08, 3.81 )
1->4
0.71 (0.48, 1.04)
0.78 (0.53, 1.15)
0.83 (0.57, 1.22 )
2->3
1.01 (0.48, 2.13)
0.98 (0.46, 2.08)
0.98 (0.48, 2.00 )
2->4
1.90 (0.76, 4.75)
1.86 ( 0.73, 4.72)
1.78 (0.70, 4.52 )
Low
1->2
1.55 (0.90, 2.67)
1.54 ( 0.89, 2.67)
1.55 (0.91, 2.64 )
Education 1->3
0.39 (0.04, 3.85)
0.31 ( 0.02, 5.08)
0.44 (0.10, 1.98 )
1->4
1.19 (0.74, 1.91)
1.14 ( 0.71, 1.82)
1.07 (0.67, 1.72 )
2->3
0.92 (0.33, 2.60)
0.97 ( 0.34, 2.78)
0.94 (0.34, 2.56 )
2->4
0.61 (0.15, 2.53)
0.59 ( 0.14, 2.51 )
0.63 (0.15, 2.55 )
Female
1->2
0.82 (0.55, 1.23)
0.85 ( 0.57, 1.27 )
0.79 (0.53, 1.18 )
1->3
1.94 (0.78, 4.79)
1.67 ( 0.69, 4.07 )
1.73 (0.84, 3.57 )
1->4
0.71 (0.52, 0.97)
0.65 ( 0.48, 0.89 )
0.67 (0.50, 0.92 )
2->3
1.66 (0.83, 3.35)
1.75 ( 0.80, 3.83 )
1.63 (0.81, 3.25 )
2->4
1.17 (0.48, 2.88)
1.21 ( 0.46, 3.19 )
1.15 (0.46, 2.89 )
AIC*
3521.48
3346.88
3298.25
Bold number: significant at 0.05 level. * Akaike information criterion.
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Figure 3.1 Transition flows of the four-state model
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Figure 3.2 Possible observed transition paths
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Figure 3.3 Baseline intensities estimated by three models for the BRAiNS data.
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Chapter 4 A four-state Semi-Markov model with interval censored data and
time-dependent covariates
4.1

Introduction
Longitudinal event-history data arises in many chronic disease studies, such as

dementia [11], diabetes [39], HIV [40], cancer [41], liver cirrhosis [26], just to name a
few. There are multiple possible states or stages in the process of the disease. For
example, in the study of dementia, although dementia is the outcome of interest, study
participants could first convert to clinically relevant states such as clinical mild
cognitive impairment (MCI) for several years before finally entering a demented state.
Participants in these longitudinal studies are usually observed over time. The outcome
data consist of times of occurrence of transitions from one state to another state and
the types of transitions that occur.
In the analysis of longitudinal event-history data, the first issue is to handle
intermediate states and final absorbing states at the same time. The final absorbing
states are usually the disease states of primary interest. However, the process of the
disease will change dramatically if participants enter into a particular intermediate
state. For example, in the development of dementia, participants with clinical MCI
will have much higher risk converting to dementia than those without clinical MCI
[20].
As an extension of survival models, Markov multi-state models [4-6, 42]
enable researchers to investigate the transitions among multiple states at the same
time. Two types of multi-state models are mainly used in practice. The multi-state
Markov chain models are not appropriate when the longitudinal data are unequally
spaced. Participants are usually assessed periodically, leading to interval censoring
observations of transitions between the states. An alternative to handle interval
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censored data is to model the transitions as a continuous-time Markov process. The
process can be fully characterized by its transition intensities. In many applications,
the Markov assumption might not be appropriate and may lead to biased conclusions.
For instance, in the study of dementia, a person often first converts to a clinically
relevant outcome such as clinical mild cognitive impairment (MCI) for several years
before finally entering a demented state. The time spent at MCI seems to have a
strong association to the future development of the dementia process. In this
manuscript, we propose a continuous-time semi-Markov model to account for the
effects of holding times on the future development of the disease process. The
proposed model allows the transition intensities to be dependent on both the calendar
time and the holding time the participant spends in the current state. This model can
also handle left-truncation, interval-censored, right censored data. Both baseline and
time-dependent covariates can be easily added into the model assuming the
proportional hazards regression form. To facilitate the model building process, we
also provide two model selection strategies and a graphic goodness-of-fit method
based on prevalence counts [43].
The remaining of this chapter is structured as follows. In Section 4.2, we detail
the model and the associated inference methods. In Section 4.3, we propose two
model selection strategies to facilitate the model building process. In Section 4.4, a
graphic goodness-of-fit method will be presented to check how the model fits the
data. Results of the application to the BRAiNS data will be presented in Section 4.5.
In the last section, we discuss the proposed method and outline some possible future
directions.
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4.2

The method
In this section, we introduce the notation and the likelihood function for the

four-state semi-Markov model. The four-state model is an extension of the widely
used “illness-death” model. We relax the commonly assumed Markov property,
letting the future evolution of the process not only depend on the current state, but
also on the entry time into the current state. Time dependent covariates can be easily
incorporated into the model through proportional hazard properties for the transition
intensities.
4.2.1

The Semi-Markov Framework
Different from a Markov process, the future of a semi-Markov process is not

only dependent on the current state but also on the time the process entry into the
current state. Let 𝑋𝑋(𝑡𝑡) be a continuous time semi-Markov process with a finite state

space S = {1,2,3,4}. Define the transition probability from state ℎ at time 𝑠𝑠 to state 𝑗𝑗
at time 𝑡𝑡 given that the process entry into state ℎ at time 𝜏𝜏ℎ as

𝑝𝑝ℎ𝑗𝑗 (𝑠𝑠, 𝑡𝑡|𝜏𝜏ℎ ) = 𝑃𝑃(𝑋𝑋(𝑡𝑡) = 𝑗𝑗|𝑋𝑋(𝑠𝑠) = ℎ, 𝜏𝜏ℎ ) 𝜏𝜏ℎ < s < t.

The associated transition intensity has the following definition

𝛼𝛼ℎ𝑗𝑗 (𝑡𝑡|𝜏𝜏ℎ ) = �

lim 𝑝𝑝ℎ𝑗𝑗 (𝑡𝑡, 𝑡𝑡 + ∆𝑡𝑡|𝜏𝜏ℎ )/∆𝑡𝑡 ,

∆𝑡𝑡→0

− � 𝛼𝛼ℎ𝑘𝑘 (𝑡𝑡|𝜏𝜏ℎ ) ,
𝑘𝑘≠ℎ

𝑗𝑗 ≠ ℎ

𝑗𝑗 = ℎ

,

which represents the instantaneous hazard of transition from the current state ℎ to

state 𝑗𝑗 at time 𝑡𝑡 given the current state ℎ and entry time 𝜏𝜏ℎ when ℎ ≠ 𝑗𝑗.

The time scale 𝑡𝑡 is the age of participants in this study. Since each subject is in

the same initial state, normal, at baseline in our motivating example, we do not have a
left truncation problem and simply assume a unique time (age 60) as the time origin
for all subjects, which is the time we assumed participant entry into the state normal.
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The strategy of dealing with initial time points is applied by Kryscio, et al. [22] and
Kapetanakis, et al.[17]. Thus we have 𝜏𝜏1 = 60.
4.2.2

Weibull Regression Model

Time dependent covariates 𝒁𝒁(𝑡𝑡) can be incorporated into the transition intensities

using the proportional intensity regression model:

𝛼𝛼ℎ𝑗𝑗 (𝑡𝑡|𝜏𝜏ℎ ) = 𝛼𝛼ℎ𝑗𝑗,0 (𝑡𝑡|𝜏𝜏ℎ ) 𝑒𝑒𝑒𝑒𝑒𝑒 �𝜷𝜷𝑇𝑇ℎ𝑗𝑗 𝒁𝒁(𝑡𝑡)� , 𝑗𝑗 ≠ ℎ .

Here 𝛼𝛼ℎ𝑗𝑗,0 (𝑡𝑡|𝜏𝜏ℎ ) is called the baseline transition intensity. We assume the baseline

intensities have the time reset property. Let 𝑤𝑤 = 𝑡𝑡 − 𝜏𝜏ℎ be the holding time the

participant has been in the current state, we have
𝛼𝛼ℎ𝑗𝑗,0 (𝑡𝑡|𝜏𝜏ℎ ) = �

𝛼𝛼ℎ𝑗𝑗,0 (𝑡𝑡 − 𝜏𝜏ℎ ) = 𝛼𝛼ℎ𝑗𝑗,0 (𝑤𝑤),
0

𝑡𝑡 ≥ 𝜏𝜏ℎ
𝑡𝑡 < 𝜏𝜏ℎ

We assume the baseline intensity functions have the Weibull form

𝛼𝛼ℎ𝑗𝑗,0 (𝑤𝑤) = 𝜆𝜆ℎ𝑗𝑗 𝜅𝜅ℎ𝑗𝑗 𝑤𝑤 𝜅𝜅ℎ𝑗𝑗−1 = 𝑒𝑒𝑒𝑒𝑒𝑒�𝛽𝛽ℎ𝑗𝑗,0 �𝜅𝜅ℎ𝑗𝑗 𝑤𝑤 𝜅𝜅ℎ𝑗𝑗−1 .

Here, the scale parameter is 𝜆𝜆ℎ𝑗𝑗 = 𝑒𝑒𝑒𝑒𝑒𝑒�𝛽𝛽ℎ𝑗𝑗,0 � > 0 and the shape parameter is 𝜅𝜅ℎ𝑗𝑗 >
0.

4.2.3

The Likelihood Function
Since we assume the target populations are all cognitively normal at the age of

60, and that participants who were not in the normal cognition state at their baseline
age are left out of the dataset, the data are left truncated. And also we only observed
the participants at discrete fixed time points, the entering times into state MCI and
dementia are interval censored. The right censored data occurs when participants drop
out of the study before they develop MCI or dementia, or is still in normal cognition
or MCI at the end of the study. There are also possibilities that some transitions might
not be observed. For example, if a participant was assessed as normal at this
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assessment and then assessed as dementia at the next assessment, it is possible that he
or she might have an observed transition from normal to MCI before finally
converting to dementia sometime between assessments. We will consider all these
cases when constructing the likelihood function.
To construct the likelihood, we let 𝐴𝐴𝑖𝑖,10 be the age before the beginning of the

study at which participants first enter into the initial state (normal), here we

have 𝐴𝐴𝑖𝑖,0 = 𝜏𝜏1 = 60. Also let 𝐴𝐴𝑖𝑖,𝑏𝑏 be the age at baseline for participant 𝑖𝑖; 𝐴𝐴𝑖𝑖,1𝑁𝑁 be the
age at the last time participant 𝑖𝑖 is observed in state 1 (normal); 𝐴𝐴𝑖𝑖,20 be the age at the

first time the participant is observed in state 2 (MCI); 𝐴𝐴𝑖𝑖,2𝑁𝑁 be the age at the first time

the participant is observed in state 2; 𝐴𝐴𝑖𝑖,𝑁𝑁 be the age at the last time participant 𝑖𝑖 had

an observation. Let 𝑈𝑈𝑖𝑖,ℎ𝑗𝑗 be the age when participant 𝑖𝑖 transitions from state ℎ to

state 𝑗𝑗, for example, 𝑈𝑈𝑖𝑖,12 is the age at the time participant transition from state 1 to
state 2 and 𝑈𝑈𝑖𝑖,23 is the age at the time participant transition from state 2 to state 3.

These ages are all interval censored. However, the transition times to death, which
are 𝑈𝑈𝑖𝑖,14 and 𝑈𝑈𝑖𝑖,24 , are known exactly. In our case we have 𝑈𝑈𝑖𝑖,14 = 𝐴𝐴𝑖𝑖,𝑁𝑁 or 𝑈𝑈𝑖𝑖,24 =
𝐴𝐴𝑖𝑖,𝑁𝑁 if the last state recorded is death. Since every subject starts at state 1, and the

process has no backward transitions, we have 𝜏𝜏2 = 𝑈𝑈𝑖𝑖,12 , which is interval
censored: 𝐴𝐴𝑖𝑖,1𝑁𝑁 < 𝜏𝜏2 = 𝑈𝑈𝑖𝑖,12 ≤ 𝐴𝐴𝑖𝑖,20. Thus we have

𝛼𝛼2𝑗𝑗 (𝑡𝑡|𝜏𝜏2 ) = 𝛼𝛼2𝑗𝑗 �𝑡𝑡|𝑈𝑈𝑖𝑖,12 �, 𝑡𝑡 ≥ 𝑈𝑈𝑖𝑖,12 .

Before we construct the likelihood for the model, we denote two transition
probabilities that will help us write the likelihood functions. First, we
write 𝑝𝑝11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝑡𝑡� = 𝑃𝑃�𝑋𝑋(𝑡𝑡) = 1|𝑋𝑋�𝐴𝐴𝑖𝑖,𝑏𝑏 � = 1�, which is the probability that the

participant is still in state normal at time 𝑡𝑡 given it was at state normal at baseline
age 𝐴𝐴𝑖𝑖,𝑏𝑏 . We have
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𝑝𝑝11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝑡𝑡� = 𝑒𝑒𝑒𝑒𝑒𝑒 �− �Λ 𝑖𝑖,1 (𝑡𝑡) − Λ 𝑖𝑖,1 �𝐴𝐴𝑖𝑖,𝑏𝑏 ���.

Here, Λ 𝑖𝑖,1 (𝑡𝑡) is the cumulative hazard function of subject 𝑖𝑖 for leaving state 1 and it
has the form:

Λ 𝑖𝑖,1 (𝑡𝑡) =

𝑡𝑡

� �𝛼𝛼12 (𝑢𝑢) + 𝛼𝛼13 (𝑢𝑢) + 𝛼𝛼14 (𝑢𝑢)�𝑑𝑑𝑑𝑑

𝐴𝐴𝑖𝑖,10 =60

We also write 𝑝𝑝22 �𝑈𝑈𝑖𝑖,12 , 𝑡𝑡� = 𝑃𝑃�𝑋𝑋(𝑡𝑡) = 2|𝑋𝑋�𝑈𝑈𝑖𝑖,12 � = 2, 𝜏𝜏2 = 𝑈𝑈𝑖𝑖,12 �, which is

the probability that the subject remains in state 2 given that it entered state 2 at
time 𝑈𝑈𝑖𝑖,12 . We have

𝑡𝑡

𝑝𝑝22 �𝑈𝑈𝑖𝑖,12 , 𝑡𝑡� = 𝑒𝑒𝑒𝑒𝑒𝑒 �− � �𝛼𝛼23 �𝑢𝑢|𝑈𝑈ℎ,12 � + 𝛼𝛼24 �𝑢𝑢|𝑈𝑈ℎ,12 �� 𝑑𝑑𝑑𝑑�
𝑈𝑈𝑖𝑖,12

There would be total 6 possible observed transition paths for a subject, as
shown in Figure 3.2. We will discuss the likelihood construction below case by case.
Path (1): the patient has no transition during the study and is still in state 1
(normal) at the end of study. In this case, the likelihood for this patient would be
𝐿𝐿𝑖𝑖,1 = 𝑃𝑃�𝑋𝑋�𝐴𝐴𝑖𝑖,𝑁𝑁 � = 1|𝑋𝑋�𝐴𝐴𝑖𝑖,𝑏𝑏 � = 1� = 𝑝𝑝11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝐴𝐴𝑖𝑖,𝑁𝑁 �
= 𝑒𝑒𝑒𝑒𝑒𝑒 �− �Λ 𝑖𝑖,1 �𝐴𝐴𝑖𝑖,𝑁𝑁 � − Λ 𝑖𝑖,1 �𝐴𝐴𝑖𝑖,𝑏𝑏 ���.

Path (2): the patient has one observed transition from state normal to state
MCI and stays in state MCI at the end of study. In this case, we have
𝐿𝐿𝑖𝑖,2 = 𝑃𝑃�𝑋𝑋�𝐴𝐴𝑖𝑖,1𝑁𝑁 � = 1, 𝑋𝑋�𝐴𝐴𝑖𝑖,20 � = 2, 𝑋𝑋�𝐴𝐴𝑖𝑖,𝑁𝑁 � = 2 |𝑋𝑋�𝐴𝐴𝑖𝑖,𝑏𝑏 � = 1�
𝐴𝐴𝑖𝑖,20

= � 𝑝𝑝11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝑈𝑈𝑖𝑖,12 �𝛼𝛼12 �𝑈𝑈𝑖𝑖,12 �𝑝𝑝22 �𝑈𝑈𝑖𝑖,12 , 𝐴𝐴𝑖𝑖,𝑁𝑁 � 𝑑𝑑𝑈𝑈𝑖𝑖,12
𝐴𝐴𝑖𝑖,1𝑁𝑁

58

Path (3): the patient has one observed transition from normal to state
dementia. In this case, because of the interval-censoring, there could be two possible
true paths, we need to take into account all the information available in such type of
incomplete data. Scenario 1, the subject might have one transition from state normal
directly to state dementia at time 𝑈𝑈𝑖𝑖,13 . Scenario 2, the subject might have two

transitions, first transition from state normal to state MCI at time 𝑈𝑈𝑖𝑖,12 then transition

from state MCI to state dementia at time 𝑈𝑈𝑖𝑖,23 . Thus, the likelihood of this path has
two parts:

𝐿𝐿𝑖𝑖,3 = 𝑃𝑃�𝑋𝑋�𝐴𝐴𝑖𝑖,1𝑁𝑁 � = 1, 𝑋𝑋�𝐴𝐴𝑖𝑖,𝑁𝑁 � = 3|𝑋𝑋�𝐴𝐴𝑖𝑖,𝑏𝑏 � = 1�
𝐴𝐴𝑖𝑖,𝑁𝑁

= � 𝑝𝑝11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝑈𝑈𝑖𝑖,13 �𝛼𝛼13 �𝑈𝑈𝑖𝑖,13 � 𝑑𝑑𝑈𝑈𝑖𝑖,13
𝐴𝐴𝑖𝑖,1𝑁𝑁
𝐴𝐴𝑖𝑖,𝑁𝑁

+ �

𝐴𝐴𝑖𝑖,𝑁𝑁

� 𝑝𝑝11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝑈𝑈𝑖𝑖,12 �𝛼𝛼12 �𝑈𝑈𝑖𝑖,12 �𝑝𝑝22 �𝑈𝑈𝑖𝑖,12 , 𝑈𝑈𝑖𝑖,23 �𝛼𝛼23 �𝑈𝑈𝑖𝑖,23 |𝑈𝑈𝑖𝑖,12 �𝑑𝑑𝑈𝑈𝑖𝑖,12 𝑑𝑑𝑈𝑈𝑖𝑖,23

𝐴𝐴𝑖𝑖,1𝑁𝑁 𝐴𝐴𝑖𝑖,1𝑁𝑁

Path (4): subject 𝑖𝑖 has one observed transition from state normal to death

without dementia. Similar in Path (3), there could be two possible scenarios. The
subject might have just one transition from state 1 directly to state 4 at time 𝐴𝐴𝑖𝑖,𝑁𝑁 ; or it
might have two transitions, first from state normal to state MCI at time 𝑈𝑈𝑖𝑖,12 then

transition from state MCI to death at time 𝐴𝐴𝑖𝑖,𝑁𝑁 . Note that in BRAiNS data the exact

age of death is recorded but the state just before death is unknown except dementia.
Thus the subject might be at either state normal or state MCI before death. The
likelihood for this path can be calculated as follows:
𝐿𝐿𝑖𝑖,4 = 𝑃𝑃�𝑋𝑋�𝐴𝐴𝑖𝑖,1𝑁𝑁 � = 1, 𝑋𝑋�𝐴𝐴𝑖𝑖,𝑁𝑁 � = 4, 𝑈𝑈𝑖𝑖,14 = 𝐴𝐴𝑖𝑖,𝑁𝑁 |𝑋𝑋�𝐴𝐴𝑖𝑖,𝑏𝑏 � = 1�
= 𝑝𝑝11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝑈𝑈𝑖𝑖,14 �𝛼𝛼14 �𝑈𝑈𝑖𝑖,14 �
𝐴𝐴𝑖𝑖,𝑁𝑁

+ � 𝑝𝑝11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝑈𝑈𝑖𝑖,12 �𝛼𝛼12 �𝑈𝑈𝑖𝑖,12 �𝑝𝑝22 �𝑈𝑈𝑖𝑖,12 , 𝐴𝐴𝑖𝑖,𝑁𝑁 �𝛼𝛼24 �𝐴𝐴𝑖𝑖,𝑁𝑁 |𝑈𝑈𝑖𝑖,12 �𝑑𝑑𝑈𝑈𝑖𝑖,12
𝐴𝐴𝑖𝑖,1𝑁𝑁
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Path (5): subject 𝑖𝑖 has two observed transitions, first transition from state

normal to state MCI at time 𝑈𝑈𝑖𝑖,12 �𝐴𝐴𝑖𝑖,1𝑁𝑁 < 𝑈𝑈𝑖𝑖,12 ≤ 𝐴𝐴𝑖𝑖,20 � and then from state MIC to

state dementia at time 𝑈𝑈𝑖𝑖,23 �𝐴𝐴𝑖𝑖,2𝑁𝑁 < 𝑈𝑈𝑖𝑖,23 ≤ 𝐴𝐴𝑖𝑖,𝑁𝑁 �. In this case we have

𝐿𝐿𝑖𝑖,5 = 𝑃𝑃�𝑋𝑋�𝐴𝐴𝑖𝑖,1𝑁𝑁 � = 1, 𝑋𝑋�𝐴𝐴𝑖𝑖,20 � = 2, 𝑋𝑋�𝐴𝐴𝑖𝑖,2𝑁𝑁 � = 2, 𝑋𝑋�𝐴𝐴𝑖𝑖,𝑁𝑁 � = 3 |𝑋𝑋�𝐴𝐴𝑖𝑖,𝑏𝑏 � = 1�
𝐴𝐴𝑖𝑖,20

𝐴𝐴𝑖𝑖,𝑁𝑁

= � � � 𝑝𝑝11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝑈𝑈𝑖𝑖,12 �𝛼𝛼12 �𝑈𝑈𝑖𝑖,12 �𝑝𝑝22 �𝑈𝑈𝑖𝑖,12 , 𝑈𝑈𝑖𝑖,23 �𝛼𝛼23 �𝑈𝑈𝑖𝑖,23 |𝑈𝑈𝑖𝑖,12 �𝑑𝑑𝑈𝑈𝑖𝑖,23 � 𝑑𝑑𝑈𝑈𝑖𝑖,12
𝐴𝐴𝑖𝑖,1𝑁𝑁

𝐴𝐴𝑖𝑖,2𝑁𝑁

Path (6): subject 𝑖𝑖 has two observed transitions, the first is from state normal

to state MCI at time 𝑈𝑈𝑖𝑖,12 �𝐴𝐴𝑖𝑖,1𝑁𝑁 < 𝑈𝑈𝑖𝑖,12 ≤ 𝐴𝐴𝑖𝑖,20 � and the second is from state MCI to
state death at time 𝐴𝐴𝑖𝑖,𝑁𝑁 . In this case we have

𝐿𝐿𝑖𝑖,6 = 𝑃𝑃�𝑋𝑋�𝐴𝐴𝑖𝑖,1𝑁𝑁 � = 1, 𝑋𝑋�𝐴𝐴𝑖𝑖,20 � = 2, 𝑋𝑋�𝐴𝐴𝑖𝑖,𝑁𝑁 −� = 2 , 𝑋𝑋�𝐴𝐴𝑖𝑖,𝑁𝑁 � = 4|𝑋𝑋�𝐴𝐴𝑖𝑖,𝑏𝑏 � = 1�
𝐴𝐴𝑖𝑖,20

= � 𝑝𝑝11 �𝐴𝐴𝑖𝑖,𝑏𝑏 , 𝑈𝑈𝑖𝑖,12 �𝛼𝛼12 �𝑈𝑈𝑖𝑖,12 �𝑝𝑝22 �𝑈𝑈𝑖𝑖,12 , 𝐴𝐴𝑖𝑖,𝑁𝑁 �𝛼𝛼24 �𝐴𝐴𝑖𝑖,𝑁𝑁 |𝑈𝑈𝑖𝑖,12 � 𝑑𝑑𝑈𝑈𝑖𝑖,12
𝐴𝐴𝑖𝑖,1𝑁𝑁

4.2.4

Parameter Estimations
The calculation of the likelihood function involves multiple integrals, which

do not have closed forms. We implement the quasi-Monte Carlo (QMC) [44] method
to approximate the likelihood. QMC will provide considerably better accuracy, with
the expected integration error of the order of 𝑁𝑁 −1 (N being the number of Halton

sequence points from the integration space), to approximate the integrations of the
likelihood function.[45].
Parameters contained in the model are the scale parameters 𝜆𝜆ℎ𝑗𝑗 = 𝑒𝑒𝑒𝑒𝑒𝑒�𝛽𝛽ℎ𝑗𝑗,0 �,

the shape parameters 𝜅𝜅ℎ𝑗𝑗 , and the regression coefficients 𝜷𝜷𝒉𝒉𝒉𝒉 , where ℎ < 𝑗𝑗, ℎ ∈

{1,2}, 𝑗𝑗 ∈ {2,3,4}. Estimation and inference on these parameters can be achieved by
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maximizing the likelihood function discussed above. We used “optim function” in R
version 3.2.2 with the quasi-Newton method to maximize the log-likelihood function
and to compute the numerically differentiated Hessian matrix. All programing was
done in R.
4.3

Model Selection Strategy
In multi-state models, there are multiple possible transition paths and each

covariate may have a different effect on different transition intensities. For example,
in our four-state model there are 5 different transition intensity functions implying
each covariate has up to 5 different coefficient parameters one per transition intensity.
Thus model selection in multi-state models is more complicated than in other models
such as linear models, logistical models, survival models, etc. In this section, we
propose two model selection strategies for multi-state models. Both strategies help us
to select the covariates and the coefficients on the associated transition path intensity
functions and to determine the initial values for fitting the final selected model.
Strategy 1 is revised forward-backward step-wise selection method. The
algorithm has the follow four steps:
Step 1. Fit a model with no covariate. Denote this model as ℳ0 .

Step 2. Add a single covariate 𝑍𝑍1 (𝑡𝑡) into the model ℳ0 . Since 𝑍𝑍1 (𝑡𝑡) would affect
each transition with different coefficient, five

parameters �𝛽𝛽12,1 , 𝛽𝛽13,1 , 𝛽𝛽14,1 , 𝛽𝛽23,1 , 𝛽𝛽24,1 � are added into the model at the same
time. Fit the model with the initial values for the baseline intensity parameters
computed in Step 1. Next, apply a backward deletion. Parameter with the
largest 𝑝𝑝 value among the newly added parameters

�𝛽𝛽12,1 , 𝛽𝛽13,1 , 𝛽𝛽14,1 , 𝛽𝛽23,1 , 𝛽𝛽24,1 � is removed from the model. Refit the model and
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repeat the above backward deletion algorithm until all covariate coefficients
associated with 𝑍𝑍1 (𝑡𝑡) are significant at level 𝑝𝑝 ≤ 0.1. Denote this model
as ℳ1 .

Step 3. Add a second covariate 𝑍𝑍2 (𝑡𝑡) into the previous model ℳ1 . Repeat Step 2.

When applying the backward deletion algorithm in this step, we only delete
the newly added parameters that are not significant at level 𝑝𝑝 ≤ 0.1.

Parameters that are already in the previous model ℳ1 are not removed even

though they might be not significant at level 𝑝𝑝 ≤ 0.1. The resulting model

after adding covariate 𝑍𝑍2 (𝑡𝑡) and applying the backward deletion procedure is

denoted as ℳ2 . Repeat the same procedure until all covariates are added in the
model. Denote the resulting model as ℳ𝑝𝑝 .

Step 4. Beginning from model ℳ𝑝𝑝 , we apply a step-wise backward selection method.
At each step, coefficient with the largest p value is removed from the model
until all the coefficients are significant at level 𝑝𝑝 ≤ 0.05.

Strategy 2 is a two stage modeling technique. The first stage is a univariate

modeling. The second stage is a multivariate modeling.
1.

Univariate modeling –We calculated one model for each covariate. Models were
said to be univariate, because only one factor was taken into account, even if it
could influence a few transitions. At this stage, covariate coefficients are not
significant at 𝑝𝑝 ≤ 0.1 level are removed from the univariate model in a stepfashion.

2.

Multivariate modeling – All the previously selected significant covariates are
included in the model. The vector of covariates were transition-specific. By a
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backward step-wise deletion procedure, each coefficient with a p-value>0.05 is
removed from the model.
4.4

Goodness of Fit
In this section, we provide a goodness-of-fit assessment for the proposed

model by the means of prevalence counts [43]. Prevalence counts provide an informal
empirical measure of state occupancy. If the model fits the data well, the expected
state occupancies by the fitted model should be close to the observed state
occupancies. By comparing the observed and expected prevalence counts, we would
have a general goodness-of-fit assessment of the fitted model.
Let 𝑋𝑋�𝑖𝑖 (𝑡𝑡) be the observed process for the multi-state model. Since the process

is observed only at some discrete time points, the transition time is interval censored
for transition from state normal to state MCI and dementia and for transition from

MCI to dementia. Thus, observed process 𝑋𝑋�𝑖𝑖 (𝑡𝑡) is unknown in the time interval with
observed transitions. For example, subject 𝑖𝑖 has an observed transition from state

normal at time 𝐴𝐴𝑖𝑖,1𝑁𝑁 to state dementia at time 𝐴𝐴𝑖𝑖,𝑁𝑁 , the value of 𝑋𝑋�𝑖𝑖 (𝑡𝑡) is unknown for

time 𝑡𝑡 ∈ �𝐴𝐴𝑖𝑖,1𝑁𝑁 , 𝐴𝐴𝑖𝑖,𝑁𝑁 �. Considering the proposed model is progressive, it is possible to
interpolate the observed prevalence at any given time 𝑡𝑡. Titman, et al. [43] suggest

assuming that the patient remains in the state they were in at the last observation. In
this manuscript, we use the midpoint rule. As in the above example we have

𝑋𝑋�𝑖𝑖 (𝑡𝑡) = �

1
3

𝑡𝑡 < �𝐴𝐴𝑖𝑖,1𝑁𝑁 + 𝐴𝐴𝑖𝑖,𝑁𝑁 �/2
𝑡𝑡 ≥ �𝐴𝐴𝑖𝑖,1𝑁𝑁 + 𝐴𝐴𝑖𝑖,𝑁𝑁 �/2

Here, we assume that there are no unobserved transitions from state normal to
state MCI in between the transition from state normal to state dementia.
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Let 𝑂𝑂1𝑗𝑗 (𝑡𝑡) be the observed prevalence counts in state 𝑗𝑗 at time 𝑡𝑡 among

subjects started in state normal at baseline age. And let 𝑂𝑂2𝑗𝑗 (𝑡𝑡) be the observed

prevalence counts in state 𝑗𝑗 at time 𝑡𝑡 among subjects having a transition to state MCI.

We have

𝑁𝑁

𝑂𝑂1𝑗𝑗 (𝑡𝑡) = � 𝐼𝐼�𝑋𝑋�𝑖𝑖 (𝑡𝑡) = 𝑗𝑗|𝑋𝑋�𝑖𝑖 �𝐴𝐴𝑖𝑖,𝑏𝑏 � = 1�𝛿𝛿1𝑖𝑖 (𝑡𝑡)
𝑖𝑖=1
𝑁𝑁

𝑂𝑂2𝑗𝑗 (𝑡𝑡) = � 𝐼𝐼�𝑋𝑋�𝑖𝑖 (𝑡𝑡) = 𝑗𝑗|𝑋𝑋�𝑖𝑖 �𝑈𝑈𝑖𝑖,12 � = 2�𝛿𝛿2𝑖𝑖 (𝑡𝑡)
𝑖𝑖=1

.

Here, 𝛿𝛿1𝑖𝑖 (𝑡𝑡) and 𝛿𝛿2𝑖𝑖 (𝑡𝑡) are indicators of whether patient 𝑖𝑖 was under observation at
time 𝑡𝑡:

and

0,
𝛿𝛿1𝑖𝑖 (𝑡𝑡) = �
1,

𝑡𝑡 > 𝐴𝐴𝑖𝑖,𝑁𝑁 𝑎𝑎𝑎𝑎𝑎𝑎 𝑋𝑋�𝑖𝑖 �𝐴𝐴𝑖𝑖,𝑁𝑁 � ∈ (1,2)
𝑜𝑜𝑜𝑜ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒

0,
1,

𝑡𝑡 > 𝐴𝐴𝑖𝑖,𝑁𝑁 𝑎𝑎𝑎𝑎𝑎𝑎 𝑋𝑋�𝑖𝑖 �𝐴𝐴𝑖𝑖,𝑁𝑁 � ∈ (1,2)
.
𝐴𝐴𝑖𝑖,𝑁𝑁 > 𝑡𝑡 ≥ 𝑈𝑈𝑖𝑖,12

𝛿𝛿2𝑖𝑖 (𝑡𝑡) = �

The calculation of 𝑂𝑂2𝑗𝑗 (𝑡𝑡) is dependent on the transition time to state MCI, we

assume 𝑈𝑈𝑖𝑖,12 = �𝐴𝐴𝑖𝑖,1𝑁𝑁 + 𝐴𝐴𝑖𝑖,20 �/2 for the purpose of calculating the prevalence counts
among these subjects. In the above observed prevalence counts, we assume that there
are no unobserved transitions. The observed prevalence counts for state MCI would
be under estimated, since we do not account for the possible unobserved transitions
from state normal to state MCI for subjects with observed transition from normal
directly to dementia or death.
The calculations of expected prevalence counts are straightforward. Denote
𝐸𝐸1𝑗𝑗 (𝑡𝑡) and 𝐸𝐸2𝑗𝑗 (𝑡𝑡) the expected prevalence counts in state 𝑗𝑗 at time 𝑡𝑡 among all

subjects and among subjects having a transition into MCI respectively. We have
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𝑁𝑁

𝐸𝐸1𝑗𝑗 (𝑡𝑡) = � 𝑃𝑃��𝑋𝑋𝑖𝑖 (𝑡𝑡) = 𝑗𝑗|𝑋𝑋𝑖𝑖 �𝐴𝐴𝑖𝑖,𝑏𝑏 � = 1�𝛿𝛿1𝑖𝑖 (𝑡𝑡)
𝑖𝑖=1
𝑁𝑁

𝐸𝐸2𝑗𝑗 (𝑡𝑡) = � 𝑃𝑃��𝑋𝑋𝑖𝑖 (𝑡𝑡) = 𝑗𝑗|𝑋𝑋𝑖𝑖 �𝑈𝑈𝑖𝑖,12 � = 2�𝛿𝛿2𝑖𝑖 (𝑡𝑡)
𝑖𝑖=1

Here the expected transition probability from state normal at baseline to state 𝑗𝑗

at time 𝑡𝑡, 𝑃𝑃��𝑋𝑋𝑖𝑖 (𝑡𝑡) = 𝑗𝑗|𝑋𝑋𝑖𝑖 �𝐴𝐴𝑖𝑖,𝑏𝑏 � = 1�, and the expected transition probability from

state MCI at time 𝑈𝑈𝑖𝑖,12 to state 𝑗𝑗 at time 𝑡𝑡, 𝑃𝑃��𝑋𝑋𝑖𝑖 (𝑡𝑡) = 𝑗𝑗|𝑋𝑋𝑖𝑖 �𝑈𝑈𝑖𝑖,12 � = 2� can be

calculated by using in the estimated model parameters and covariate values. Here we
assume 𝑈𝑈𝑖𝑖,12 = �𝐴𝐴𝑖𝑖,1𝑁𝑁 + 𝐴𝐴𝑖𝑖,20 �/2.

A comparison of the observed prevalence counts and the expected prevalence

counts by the fitted model can be made by plotting the observed prevalence and
expected prevalence functions on the same graph.
4.5

Application
BRAiNS is a longitudinal cohort of 1,030 older participants at the University

of Kentucky’s Alzheimer’s disease Center (UK ADC) [36]. Participants consent to
extensive annual cognitive and clinical examinations. The sample included in this
study consists of 531 participants, who were assessed at least two times, and were at
least 60 years old at baseline. All subjects were cognitively intact at study entry. The
baseline age for the sample is 73.2 (STD=7.4) years. We have 6 possible transition
paths among the four states under consideration. Table 4.1 presents the frequency and
percentage for each observed transition path.
The list of factors to be examined as potential risks for transitions among the
states were selected by matching factors reported in the literature with the data
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elements collected on participants in the BRAiNS cohort. The factors examined and
entered as indicator variables in the statistical models below are: APOE4 carrier status
(with and without an ε4 allele), female gender, low education (defined as high school
or less), family history of dementia among 1st degree relatives, baseline current
smoker and presence of Type II diabetes. These covariates are all baseline covariates.
See Table 4.2 for the summary of these covariates. A time dependent covariate Age
Group will also be added to the transition intensity functions from state MCI to
dementia and death. Age Group has two levels and it is defined as follows:
𝐴𝐴𝐴𝐴𝐴𝐴 𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺(𝑡𝑡) = �

0,
1,

𝑡𝑡 < 82.5
.
𝑡𝑡 ≥ 82.5

Here, the time scale 𝑡𝑡 is the age and the cut point 82.5 is set to be around the

median value of midpoint of the time interval who transition from state normal to
state MCI.
We applied both model selection strategies presented in Section 4, which

resulted in the same final model. The parameter estimates of the final model are listed
in Table 4.3. The time dependent covariate Age Group is not significant on the
intensity from clinical MCI to dementia, but it is significant on the transition path
from MCI to death. As expected, older subjects have higher mortality rate for these
have been in clinical MCI. Having at least one APOE4 allele increases the log hazard
of transition from NSI into clinical MCI. Female gender has lower hazard for the
transition from NSI to death than male. And baseline smoker increase the intensity
rate for both the transition from NSI to death and from clinical MCI to dementia.
Family history of dementia and baseline type II diabetes are not significant in this
model.
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In left panel of Figure 4.3, we plotted the baseline transition intensities against
age for the three transitions from NSI to clinical MCI, from NSI to dementia and from
NSI to death. The dark solid line represents the intensity function for the transition
from NSI to clinical MCI. The dark dot line represents the intensity for the transition
path from NSI to dementia. And the light dot line represents the intensity of the
transition from NSI to death. The plots show that the intensities for the transition from
NSI to clinical MCI and death increase steadily with the later has a higher increase
rate; the transition intensity for the path from NSI directly to dementia remain flat
under age 80, then it begins to increase as subject gets older.
In the right panel of Figure 4.3, we plotted the baseline transition intensities
from clinical MCI to either dementia or death against the time since subject first went
into clinical MCI state. The dark solid line represents the transition intensity of path
from clinical MCI to dementia. The dark dot line represents the transition intensity of
the path from clinical MCI to death for these older than 82.5 years of age. And the
light dot line represent the intensity of the path form clinical MCI to death for these
who are younger than 82.5 years of age. In these plots, the intensity rate of the
transition from clinical MCI to dementia is relatively flat against the years the subject
has spent in the MCI state. The intensities of both age groups for transition from MCI
to death increase steadily as subjects spend more time on state MCI. As we noted in
the plots, older subjects have higher increased rates than younger subjects.
We check the goodness-of-fit of the model by the prevalence plots discussed
in Section 5. The goodness of fit plots are presented in Figure 4.4 and Figure 4.5. The
dots are the observed prevalence counts, and the solid dark lines are the expected
prevalence counts in these plots. Figure 4.4 presents the prevalence counts for all
subjects started at state NSI. Figure 4.5 presents the prevalence counts for those
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subjects having an observed transition to MCI. Except for the prevalence counts for
MCI in Figure 4.4, there is a good agreement between the expected prevalence and
the observed prevalence, which shows the proposed model is a good fit to the data.
One possible reason for the disagreement between observed and expected prevalence
of MCI for those subjects started at NSI state in Figure 4.4 is that there might be
unobserved transitions from NSI to MCI due to the interval censoring.
4.6

Discussion
In this chapter we proposed a four-state continuous-time semi-Markov model

applicable for left truncated, interval and right censored data. The proposed model
also allows time-dependent covariates. Two model selection strategies are proposed to
help select the “best” model that both fits the data and has a manageable number of
parameters.
Despite this connection between our semi-Markov model and the one
proposed by Foucher, et al. [16] and Kryscio, et al. [22], the modeling techniques are
different. In their models, the semi-Markov process was modeled through two
separate parts. The first part models one-step transition probabilities using standard
logistic models; and the second part models the hold times given the transition paths.
We need two coefficient parameters for each covariate on each possible transition
path; one coefficient assesses its effect on transition probability and the other one
assesses its effects on the holding time if that transition occurs. In our model, we
modeled the process through the transition intensities. We allow the transition
intensities to be dependent on both the calendar time and the holding time the subject
has been in the state. We need only one parameter for each covariate on each
transition path. And our model also allows time-dependent covariates.
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The graphic goodness-of-fit method proposed in Section 4.5 can only be used
a rough measurement of how will the model fits the data, since the true observed
prevalence counts are unknown because of the interval-censoring. The observed
prevalence counts calculated using the mid-point rule are usually under-estimated for
intermediate states, since the unobserved transitions into these states are ignored.
More sensitive goodness-of-fit tools are needed to for multi-state models.
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Table 4.1 Frequency of each transition type
Observed Path
N
NSI -> NSI
184
NSI -> MCI
50
NSI -> Dementia
52
NSI -> Death
190
NSI -> MCI -> Dementia
36
NSI -> MCI -> Death
19
All
531

Percent
34.65
9.42
9.79
35.78
6.78
3.58
100

Table 4.2 Summary of the fixed covariates
Baseline Characteristic
N
APOE4
160
Low Education
187
Female
334
Family history of dementia
214
Baseline smoker
49
Type II diabetes
44

Percent
30.3
35
63.1
40.3
9.2
8.3
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Table 4.3 Parameter estimates for the four-state semi-Markov model
Covariate
Regression coefficient Estimation S.E. P value
Shape parameters
2.467 0.256
0.000
𝜅𝜅12
5.613 1.472
0.000
𝜅𝜅13
3.869 0.261
0.000
𝜅𝜅14
1.119 0.121
0.000
𝜅𝜅23
2.606 0.455
0.000
𝜅𝜅24
𝛽𝛽
Model intercepts
-9.138 0.892
0.000
12,0
𝛽𝛽13,0
-21.554 5.283
0.000
𝛽𝛽14,0
-13.274 0.907
0.000
𝛽𝛽23,0
-1.732 0.233
0.000
𝛽𝛽24,0
-6.089 1.025
0.000
𝛽𝛽24,𝐺𝐺
Age group
1.349 0.659
0.041
𝛽𝛽12,𝐴𝐴
APOE4
0.717 0.182
0.000
𝛽𝛽14,𝐹𝐹
Female
-0.328 0.147
0.026
𝛽𝛽
Baseline Smoker
0.878 0.210
0.000
14,𝑆𝑆
𝛽𝛽23,𝑆𝑆
1.448 0.611
0.018
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Figure 4.1 Model structure of the four-state model
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Figure 4.2 Possible observed transition path of a participant
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Figure 4.3 Baseline transition intensity plots.
Left panel: dark solid line-from NSI to clinical MCI; dark dot line-from NSI to
dementia; light dot-from NSI to death.
Right panel: dark solid line-from clinical MCI to dementia; dark dot line-from clinical
MCI to death (older group); light dot line-form clinical MCI to death (younger group)
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Figure 4.4: Prevalence plots for all the subjects started at NSI at 60 years old. Dots:
Observed prevalence counts; Lines: expected prevalence counts.
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Figure 4.5 Prevalence plots for these subjects having an observed transition to MCI
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Chapter 5 Discussions and Future Research
In dementia studies, clinical assessments of a participants’ cognitive status is
taken periodically at discrete visit time points; and the cognitive status can be
classified into different states. This type of longitudinal data is commonly modeled by
discrete-time Markov chain models. Since the clinical assessments are taken
periodically at discrete time points, the transition times from one state to another state
are interval-censored. Another problem caused by the discrete-time observation
scheme is that some transitions might not be observed. In this dissertation, we
explored the use of continuous-time multi-state models to analyze this type of
longitudinal data raised in many chronic disease studies.
First, we compared the two types of multi-state models, discrete-time Markov
chain model and continuous-time Markov process model. Our study showed that
when the data are equally-spaced the two types models perform equally well.
However, when the data are not equally-spaced, the continuous-time Markov process
model has better performance than the discrete-time Markov chain model. The
Markov chain model is biased when the data is unequally-spaced. Thus, our
recommendation is that when the data are equally-spaced, either type of multi-state
model can be used. The discrete-time Markov chain model might be more attractive to
some researchers since it can be solved through standard statistical software. When
the data are unequally-spaced, the continuous-time process model is recommended.
Calculations involved in the general continuous-time Markov process model
could be very complex. Time-homogenous assumption is often used to simplify these
calculations. However, the time-homogenous assumption is not appropriate in some
cases. As we known, the hazards of developing dementia and death are heavily
depended on a participants’ age. Older people generally have higher risk of
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developing dementia or risk of mortality. In this dissertation, we propose a Weibull
Markov four-state model with two transient states and two absorbing states. By using
the Weibull hazard form, we were able to model a variety of shapes for the transition
intensities. This methodology can be easily generalized to models with more states as
long as there are no backward transitions. With backward transitions, the likelihood
calculation under the Weibull model will be complex, thus more powerful numerical
calculation method should be developed in this case. This would be an interesting
possible future research topic.
The Markov assumption is very common in the literature. Relaxing the
Markov assumption is a challenging but also an important topic. As we know, in some
chronic diseases studies the past history of the disease would have large impact on the
future development of the disease. For example, beside the participant’s age, the time
that participant has stayed in state MCI would also have an impact on its transition
hazards to dementia and death. In this dissertation, we proposed a semi-Markov
model to allow the disease process not only depended on the participants’ age but also
on the time they have stayed on the current state. The importance of this model is that
it helps us understand the participants’ transition hazards and future transition
probabilities based on their time stayed in the current state, thus we can treat
participants differently according to the time they have stayed in some critical states,
i.e. MCI.
Both the Markov model and semi-Markov model we presented in this
dissertation requires the data contains no backward transitions. Treating backward
transitions in a discrete-time observation scheme in Markov model and semi-Markov
model is challenging in two ways. First, transition times are interval-censored. With
interval-censored data, multiple integrations are involved in likelihood calculations.
78

Second, there are unobserved transitions. In a multi-state model with backward
transitions, theoretically there are infinite numbers of unobserved transitions.
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Appendices
A. SAS codes for Chapter 2
/********************************************************************/
/*1 Simulation Study*/
/********************************************************************/
PROC IML; reset storage= P1Sim.W1Sim;
START TranPD(parms,z);
P=J(4,4,0);
int1=parms[1];int2=parms[2];int3=parms[3];
ps1=parms[4];ps2=parms[5];ps3=parms[6];
z1=parms[7];z2=parms[8];z3=parms[9]; ps=1;
pexp1=exp(int1+ps1*ps+z1*z); pexp2=exp(int2+ps2*ps+z2*z);
pexp3=exp(int3+ps3*ps+z3*z);
P[1,2]=pexp1/(1+pexp1+pexp2+pexp3); P[1,3]=pexp2/(1+pexp1+pexp2+pexp3);
P[1,4]=pexp3/(1+pexp1+pexp2+pexp3); P[1,1]=1/(1+pexp1+pexp2+pexp3);
ps=0;
pexp1=exp(int1+ps1*ps+z1*z); pexp2=exp(int2+ps2*ps+z2*z);
pexp3=exp(int3+ps3*ps+z3*z);
P[2,2]=pexp1/(1+pexp1+pexp2+pexp3); P[2,3]=pexp2/(1+pexp1+pexp2+pexp3);
P[2,4]=pexp3/(1+pexp1+pexp2+pexp3); P[2,1]=1/(1+pexp1+pexp2+pexp3);
return(P);
FINISH TranPD;
START TranPC(parms,z);
Q=J(4,4,0);
Q[1,2]=exp(parms[1]+parms[7]*z); Q[1,3]=exp(parms[2]+parms[8]*z);
Q[1,4]=exp(parms[3]+parms[9]*z); Q[1,1]=-Q[1,2]-Q[1,3]-Q[1,4];
Q[2,1]=exp(parms[4]+parms[10]*z); Q[2,3]=exp(parms[5]+parms[11]*z);
Q[2,4]=exp(parms[6]+parms[12]*z); Q[2,2]=-Q[2,1]-Q[2,3]-Q[2,4];
A=teigvec(Q); V=teigval(Q); D=diag(exp(V[,1])); P=A*D*inv(A); return(P);
FINISH TranPC;
START TrueP(parms,z);
Q=J(4,4,0); Q[1,2]=exp(log(parms[1])+parms[7]*z);
Q[1,3]=exp(log(parms[2])+parms[8]*z); Q[1,4]=exp(log(parms[3])+parms[9]*z);
Q[1,1]=-Q[1,2]-Q[1,3]-Q[1,4];
Q[2,1]=exp(log(parms[4])+parms[10]*z); Q[2,3]=exp(log(parms[5])+parms[11]*z);
Q[2,4]=exp(log(parms[6])+parms[12]*z); Q[2,2]=-Q[2,1]-Q[2,3]-Q[2,4];
A=teigvec(Q); V=teigval(Q); D=diag(exp(V[,1])); P=A*D*inv(A); return(P);
FINISH TrueP;
START W1Sim(type, Nsim);
row=J(1,12,0); rows=J(1,12,0);
do iSim=1 to Nsim;
Submit type;
Data W1Sim1;
do subject=1 to 500;
z=RAND('BERNOULLI',0.4); time=0; output;
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do i=1 to 15;
if &type=1 then duration=1; else if &type=2 then
duration=RAND('NORMAL',1,0.5);
else if &type=3 then duration=RAND('NORMAL',1,1.5);
if duration<0.25 then duration=0.25; time=time+duration; output;
end;
end;
Run;
Endsubmit;
Run ExportDataSetToR("W1Sim1", "W1Sim1" );
Submit /R;
library("msm")
qmatrix <- rbind(c(0, 0.25, 0.03, 0.05), c(0.2,0, 0.15, 0.05 ), c(0,0,0,0),
c(0,0,0,0))
W1Sim2=simmulti.msm(W1Sim1, qmatrix,
covariates=list(z = c(0.5,-0.2,0,
-0.3, 0.15, 0)), death=4)
ObsL.msm <-msm(state ~ time, subject=subject, data =W1Sim2,
covariates = list("1-2" =~z, "1-3"=~z, "2-1"=~z,"2-3"=~z),qmatrix =qmatrix,
death=4,center=FALSE, method = "BFGS", control = list(fnscale = 4000,
maxit = 10000))
EstR=ObsL.msm$estimates
Endsubmit;
Run ImportDatasetFromR("W1Sim2", "W1Sim2" ); Run
ImportMatrixFromR(EstC, "EstR" );
Submit;
Data W1Sim3; set W1Sim2; by subject time; Pstate=lag(state);
if first.subject ne 1 then output; keep subject time Z state pstate; Run;
Data W1Sim4; set W1Sim3;if state=1 then state=5;if pstate=2 then pstate=0; Run;
ods select none;
Proc CATMOD data=W1Sim4; direct pstate Z; model state=pstate Z;
ods output Estimates=EstD; Run;
ods select all;
Endsubmit;
Use EstD; read all var{estimate} into parms; close EstD;
PD0=TranPD(parms,0);row[1]=type;row[2]=isim;row[3]=1;row[4]=0;row[5:8]=
pd0[1,];row[9:12]= pd0[2,];
if iSim=1 then rows=row; else rows=rows//row;
PD1=TranPD(parms,1); row[1]=type; row[2]=iSim; row[3]=1;
row[4]=1; row[5:8]=PD1[1,];row[9:12]=PD1[2,];rows=rows//row;
PC0=TranPC(EstC,0); row[1]=type; row[2]=iSim; row[3]=2; row[4]=0;
row[5:8]=PC0[1,]; row[9:12]=PC0[2,];rows=rows//row;
PC1=TranPC(EstC,1);row[1]=type; row[2]=iSim; row[3]=2; row[4]=1;
row[5:8]=PC1[1,]; row[9:12]=PC1[2,];rows=rows//row;
End;
varnames={"Type" "IDSim" "Method" "Z" "P11" "P12" "P13" "P14" "P21" "P22"
"P23" "P24"};
create W1Sim from rows[colname=varNames];append from rows; close W1Sim;
FINISH W1Sim;
STORE module=_all_;
Quit;
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PROC IML;
reset storage= P1Sim.W1Sim; /* set location for storage */ load module=_all_;
call W1Sim(1,1000); Submit; Data W1Sim1; set W1Sim; Run; Endsubmit;
call W1Sim(2,1000); Submit; Data W1Sim2; set W1Sim; Run; Endsubmit;
call W1Sim(3,1000); Submit; Data W1Sim3; set W1Sim; Run; Endsubmit;
Quit;
/********************************************************************/
/*2 Application to the Nun’s data*/
/********************************************************************/
/*Discrete-time MSM*/
Data Nun_p1; set Nun_4state; where priorstate=1; run;
PROC logistic data=nun_p1;model currentstate(ref="1")=Bage apoe4/link=glogit;run;
Data Nun_p2; set Nun_4state; where priorstate=2; run;
PROC logistic data=nun_p2;model currentstate(ref="2")=Bage apoe4/link=glogit;run;
Data Nun_p3; set Nun_4state; where priorstate=3; run;
PROC logistic data=nun_p3;model currentstate(ref="3")=Bage apoe4/link=glogit;run;
/*Continous-time MSM*/
PROC IML;
START loglhm(parms) global(dataset, error);
n=nrow(dataset);Q=J(4,4,0); logLike=.0;
do i=1 to n;
first_id=dataset[i,1];page=dataset[i,2];cage=dataset[i,3];pstate=dataset[i,4];
cstate=dataset[i,5]; bage=dataset[i,6]; apoe4=dataset[i,7];
Q[1,2]=exp(parms[1]+parms[8]*bage+parms[15]*apoe4);
Q[1,3]=exp(parms[2]+parms[9]*bage+parms[16]*apoe4);
Q[1,4]=exp(parms[3]+parms[10]*bage+parms[17]*apoe4);
Q[2,1]=exp(parms[4]+parms[11]*bage+parms[18]*apoe4);
Q[2,3]=exp(parms[5]+parms[12]*bage+parms[19]*apoe4);
Q[2,4]=exp(parms[6]+parms[13]*bage+parms[20]*apoe4);
Q[3,4]=exp(parms[7]+parms[14]*bage+parms[21]*apoe4);
Q[1,1]=-Q[1,2]-Q[1,3]-Q[1,4]; Q[2,2]=-Q[2,1]-Q[2,3]-Q[2,4]; Q[3,3]=-Q[3,4];
A=teigvec(Q); V=teigval(Q);D=diag(exp(V[,1]*(cage-page))); P=A*D*inv(A);
if cstate=4 then Li=P[pstate,1]*Q[1,4]+P[pstate,2]*Q[2,4]+P[pstate,3]*Q[3,4];
else Li=P[pstate,cstate]; if Li<=0 then error=error+1;
else logLike=logLike+log(Li);
end; return(-logLike);
FINISH loglhm;
USE Nun;
Read all var{ID priorage currentage priorstate currentstate bage apoe4} into dataset;
CLOSE Nun;
h0={-2.8451 -4.6193 -3.8569 -1.7184 -1.8959 -1.2406 -1.6418
0.0887 0.1269 0.0638 0.0100 0.0381 -0.0211 0.0364
0.4383 0.0941 0.3494 -0.6053 0.4893 -0.5624 0.0110};
error=0; call nlpnra(rc,xres,"loglhm",h0); estimate=xres` ; call
nlpfdd(f,g,hes1,"loglhm",estimate);
cov=inv(hes1); stderr=sqrt(abs(vecdiag(cov)));
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z=abs(estimate/stderr);p=2*(1-probnorm(z));
print error f; print estimate stderr p; print cov;
QUIT;
/********************************************************************/
/*3 Transition probability plots*/
/********************************************************************/
%MACRO TransP(Age,Bage,APOE4);
PROC IML;
START TranPMD(parms, Age, Bage, APOE4);
P=J(4,4,0);
/*Bage APOE4 age p11 p12 p13 p14 p21 p22 p23 p24 p33 p34*/
rows={0 0 0 0 0 0 0 0 0 0 0 0 0};
pexp11=1;
pexp12=exp(parms[1]+parms[8]*bage+parms[15]*apoe4);
pexp13=exp(parms[2]+parms[9]*bage+parms[16]*apoe4);
pexp14=exp(parms[3]+parms[10]*bage+parms[17]*apoe4);
pexp22=1;
pexp21=exp(parms[4]+parms[11]*bage+parms[18]*apoe4);
pexp23=exp(parms[5]+parms[12]*bage+parms[19]*apoe4);
pexp24=exp(parms[6]+parms[13]*bage+parms[20]*apoe4);
pexp33=1;
pexp34=exp(parms[7]+parms[14]*bage+parms[21]*apoe4);
pexp1=pexp11+pexp12+pexp13+pexp14;
P[1,1]=pexp11/pexp1; P[1,2]=pexp12/pexp1; P[1,3]=pexp13/pexp1;
P[1,4]=pexp14/pexp1;
pexp2=pexp21+pexp22+pexp23+pexp24;
P[2,1]=pexp21/pexp2; P[2,2]=pexp22/pexp2; P[2,3]=pexp23/pexp2;
P[2,4]=pexp24/pexp2;
P[3,3]=pexp33/(pexp33+pexp34); P[3,4]=pexp34/(pexp33+pexp34); P[4,4]=1;
do i=0 to Age;
if i=0 then TPM=I(4); else TPM=TPM*P;
row={0 0 0 0 0 0 0 0 0 0 0 0 0}; row[1]=Bage; row[2]=APOE4; row[3]=i;
row[4]=TPM[1,1]; row[5]=TPM[1,2]; row[6]=TPM[1,3]; row[7]=TPM[1,4];
row[8]=TPM[2,1]; row[9]=TPM[2,2]; row[10]=TPM[2,3]; row[11]=TPM[2,4];
row[12]=TPM[3,3]; row[13]=TPM[3,4];rows=rows//row;
end;
varnames={"Bage" "APOE4" "Age" "P11D" "P12D" "P13D" "P14D" "P21D"
"P22D" "P23D" "P24D" "P33D" "P34D"};
create TranPMD from rows[COLNAME=varNames];append from rows; close
TranPMD;
FINISH TranPMD;
START TranPMC(parms,Age,Bage, APOE4);
Q=J(4,4,0); rows={0 0 0 0 0 0 0 0 0 0 0 0 0};
Q[1,2]=exp(parms[1]+parms[8]*bage+parms[15]*apoe4);
Q[1,3]=exp(parms[2]+parms[9]*bage+parms[16]*apoe4);
Q[1,4]=exp(parms[3]+parms[10]*bage+parms[17]*apoe4);
Q[1,1]=-Q[1,2]-Q[1,3]-Q[1,4];
Q[2,1]=exp(parms[4]+parms[11]*bage+parms[18]*apoe4);
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Q[2,3]=exp(parms[5]+parms[12]*bage+parms[19]*apoe4);
Q[2,4]=exp(parms[6]+parms[13]*bage+parms[20]*apoe4);
Q[2,2]=-Q[2,1]-Q[2,3]-Q[2,4];
Q[3,4]=exp(parms[7]+parms[14]*bage+parms[21]*apoe4);
Q[3,3]=-Q[3,4];
A=teigvec(Q); V=teigval(Q); D=diag(exp(V[,1])); P=A*D*inv(A);
do i=0 to Age;
if i=0 then TPM=I(4); else TPM=TPM*P;
row={0 0 0 0 0 0 0 0 0 0 0 0 0}; row[1]=Bage; row[2]=APOE4; row[3]=i;
row[4]=TPM[1,1]; row[5]=TPM[1,2]; row[6]=TPM[1,3]; row[7]=TPM[1,4];
row[8]=TPM[2,1]; row[9]=TPM[2,2]; row[10]=TPM[2,3]; row[11]=TPM[2,4];
row[12]=TPM[3,3]; row[13]=TPM[3,4];rows=rows//row;
end;
varnames={"Bage" "APOE4" "Age" "P11C" "P12C" "P13C" "P14C" "P21C"
"P22C" "P23C" "P24C" "P33C" "P34C"};
create TranPMC from rows[COLNAME=varNames];append from rows; close
TranPMC;
FINISH TranPMC;
Data TranPData; merge tranpmd tranpmc; age=age+80; by age; where bage ne 0;
PROC SGplot data=TranPData noautolegend;
SERIES x=age y=p13C/lineattrs=(color=black pattern=1 thickness=2);
SERIES x=age y=p13D/lineattrs=(color=black pattern=2 thickness=2);
xaxis label="Age" labelattrs=(size=16 weight=bold)
valueattrs=(size=16 weight=bold) ;
yaxis label="Probability" labelattrs=(size=16 weight=bold)
valueattrs=(size=16 weight=bold) max=0.16;
Run;
PROC SGplot data=TranPData noautolegend;
SERIES x=age y=p23C/lineattrs=(color=black pattern=1 thickness=2);
SERIES x=age y=p23D/lineattrs=(color=black pattern=2 thickness=2);
xaxis label="Age" labelattrs=(size=16 weight=bold)
valueattrs=(size=16 weight=bold);
yaxis label="Probability" labelattrs=(size=16 weight=bold)
valueattrs=(size=16 weight=bold) values=(0 0.10 0.20 0.30);
Run;
%MEND;
/********************************************************************/
/*4 Goodness-of_fit: prevelance*/
/********************************************************************/
Data NunPrev; set Nun;
if first_id then do; state=priorstate; vage=priorage-75; output; end;
state=currentstate; vage=currentage-75; output; keep id vage state bage lage death;
Run;
Data NunPrev; set Nunprev; by id vage; first_id=0; last_id=0;
if first.id then first_id=1;
if last.id then last_id=1; age=ceil(vage);
Run;
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PROC IML;
START PrevObs;
use nunprev;read all var{id age state first_id lage death} into dataset;close nunprev;
n=nrow(dataset); obsv=J(617*40,7,0); Idn=0;
do i=1 to n;
id=dataset[i,1]; age=dataset[i,2]; state=dataset[i,3]; first_id=dataset[i,4];
lage=dataset[i,5]; death=dataset[i,6];
if death=0 then cutage=lage; else cutage=40;
if first_id=1 then Idn=Idn+first_id; cstate=state;
do j=1 to 40;
obsv[(idn-1)*40+j, 1]=id; obsv[(idn-1)*40+j, 2]=j;
if j>=age & j<=cutage then do;
obsv[(idn-1)*40+j, 3]=cstate;
if cstate=1 then obsv[(idn-1)*40+j, 4:7]={1 0 0 0};
else if cstate=2 then obsv[(idn-1)*40+j, 4:7]={0 1 0 0};
else if cstate=3 then obsv[(idn-1)*40+j, 4:7]={0 0 1 0};
else if cstate=4 then obsv[(idn-1)*40+j, 4:7]={0 0 0 1};
end;
end;
end;
varnames={"ID" "Age" "state" "state1" "state2" "state3" "state4" };
create PrevObs from obsv[colname=varNames];append from obsv; close PrevObs;
FINISH prevObs;
Run PrevObs;
Quit;
PROC SQL;
create table PrevObsP as select Age, sum(state1) as state1_OBS, sum(state2) as
state2_OBS,
sum(state3) as state3_OBS, sum(state4) as state4_OBS from PrevObs group by age;
Quit;
Data EpC; set Nun_4state; where first_id=1; keep id bstate bage apoe4 lage death;
RUN;
Proc IML;
START PrevEstC(parms);
use EpC; read all var {ID bstate bage apoe4 lage death } into Dataset; close EpC;
prevc=J(617*40,10,0); Q=J(4,4,0);
do i=1 to 617;
id=dataset[i,1]; bstate=dataset[i,2]; bage=dataset[i,3];
apoe4=dataset[i,4]; lage=dataset[i,5]; death=dataset[i,6];
Q[1,2]=exp(parms[1]+parms[8]*bage+parms[15]*apoe4);
Q[1,3]=exp(parms[2]+parms[9]*bage+parms[16]*apoe4);
Q[1,4]=exp(parms[3]+parms[10]*bage+parms[17]*apoe4);
Q[2,1]=exp(parms[4]+parms[11]*bage+parms[18]*apoe4);
Q[2,3]=exp(parms[5]+parms[12]*bage+parms[19]*apoe4);
Q[2,4]=exp(parms[6]+parms[13]*bage+parms[20]*apoe4);
Q[3,4]=exp(parms[7]+parms[14]*bage+parms[21]*apoe4);
Q[1,1]=-Q[1,2]-Q[1,3]-Q[1,4]; Q[2,2]=-Q[2,1]-Q[2,3]-Q[2,4]; Q[3,3]=-Q[3,4];
A=teigvec(Q); V=teigval(Q);
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do age=1 to 40;
prevc[(i-1)*40+age,1]=i; prevc[(i-1)*40+age,2]=age;
prevc[(i-1)*40+age,3]=bstate;
prevc[(i-1)*40+age,4]=bage; prevc[(i-1)*40+age,5]=lage;
prevc[(i-1)*40+age,6]=death;
if death=0 then cutage=lage; else cutage=40;
if age>=bage & age<=cutage then do;
D=diag(exp(V[,1]*(age-bage))); P=A*D*inv(A);
prevc[(i-1)*40+age,7]=P[bstate,1]; prevc[(i-1)*40+age,8]=P[bstate,2];
prevc[(i-1)*40+age,9]=P[bstate,3]; prevc[(i-1)*40+age,10]=P[bstate,4];
end;
end;
end;
varnames={"ID" "Age" "bstate" "bage" "lage" "death" "state1" "state2"
"state3" "state4" };
create Prevc from prevc[COLNAME=varNames];append from prevc; close prevc;
FINISH PrevEstC;
Proc IML;
START PrevEstD(parms);
use EpC; read all var {ID bstate bage apoe4 lage death } into Dataset; close EpC;
prevd=J(617*40,10,0); P=J(4,4,0);
do i=1 to 617;
id=dataset[i,1]; bstate=dataset[i,2]; bage=dataset[i,3];
apoe4=dataset[i,4]; lage=dataset[i,5]; death=dataset[i,6];
pexp11=1; pexp12=exp(parms[1]+parms[8]*bage+parms[15]*apoe4);
pexp13=exp(parms[2]+parms[9]*bage+parms[16]*apoe4);
pexp14=exp(parms[3]+parms[10]*bage+parms[17]*apoe4);
pexp22=1; pexp21=exp(parms[4]+parms[11]*bage+parms[18]*apoe4);
pexp23=exp(parms[5]+parms[12]*bage+parms[19]*apoe4);
pexp24=exp(parms[6]+parms[13]*bage+parms[20]*apoe4);
pexp33=1; pexp34=exp(parms[7]+parms[14]*bage+parms[21]*apoe4);
pexp1=pexp11+pexp12+pexp13+pexp14;
P[1,1]=pexp11/pexp1; P[1,2]=pexp12/pexp1;
P[1,3]=pexp13/pexp1; P[1,4]=pexp14/pexp1;
pexp2=pexp21+pexp22+pexp23+pexp24;
P[2,1]=pexp21/pexp2; P[2,2]=pexp22/pexp2;
P[2,3]=pexp23/pexp2; P[2,4]=pexp24/pexp2;
P[3,3]=pexp33/(pexp33+pexp34); P[3,4]=pexp34/(pexp33+pexp34); P[4,4]=1;
TPM=I(4);
do age=1 to 40;
TPM=TPM*P;
prevd[(i-1)*40+age,1]=i; prevd[(i-1)*40+age,2]=age;
prevd[(i-1)*40+age,3]=bstate;
prevd[(i-1)*40+age,4]=bage; prevd[(i-1)*40+age,5]=lage;
prevd[(i-1)*40+age,6]=death;
if death=0 then cutage=lage; else cutage=40;
if age>=bage & age<=cutage then do;
prevD[(i-1)*40+age,7]=TPM[bstate,1];
prevD[(i-1)*40+age,8]=TPM[bstate,2];
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prevD[(i-1)*40+age,9]=TPM[bstate,3];
prevD[(i-1)*40+age,10]=TPM[bstate,4];
end;
end;
end;
varnames={"ID" "Age" "bstate" "bage" "lage" "death" "state1" "state2"
"state3" "state4" };
create PrevD from prevD[colname=varNames];append from prevD; close prevD;
FINISH PrevEstD;
Quit;
B. SAS codes for Non-homogenous Markov Model
/********************************************************************/
/*1. %Macro SimData(SimN,SubjN); */
/********************************************************************/
options set=R_HOME='C:\Program Files\R\R-2.15.2';
%Macro SimData(SimN,SubjN,betas);
%let rowN=%eval(&SimN * &SubjN);
PROC IML;
Nrows=&rowN; SN=&SimN; SbjN=&SubjN;
%include "~ \GenDataR.txt";
RUN ImportDataSetFromR("SimH&SubjN", "SimH");
RUN ImportDataSetFromR("SimG&SubjN", "SimG");
Quit;
%Mend SimData;
/********************************************************************/
/*2. %Macro DataPrep(Dataset); */
/********************************************************************/
%Macro DataPrep(Dataset);
Data SimD1; set &Dataset;
rename V1=SimN V2=Id V3=T1 V4=T2 V5=T3 V6=T4 V7=T5 V8=Z; Run;
Data SimD2; set SimD1;
if T1<T2 and T1<T3 then do;State1=2;T=T1;TL1=floor(T);TR1=ceil(T);end;
if T2<T1 and T2<T3 then do;State1=3;T=T2;TL1=floor(T);TR1=ceil(T);end;
if T3<T1 and T3<T2 then do;State1=4;T=T3;TL1=floor(T);TR1=T;end;
if T>25 then do; TL1=25; TR1=25; State1=1; end;
if State1=2 then do;
if T4<T5 then do; State2=3; TT=T+T4; TL2=floor(TT); TR2=ceil(TT);end;
if T5<T4 then do; State2=4; TT=T+T5; TL2=floor(TT); TR2=TT;end;
if TT>25 then do; State2=2; TL2=25;TR2=25; end;
end;
if TL1=TL2 then do;State1=State2; State2=.; TR1=TR2; TL2=.; TR2=.; end;
RUN;
Data SimD3; set SimD2;
if State1=1 then do;case=1; TL=0; TR=TR1;output;end;
if State1=2 then do;
case=1; TL=0; TR=TL1; output; case=2; TL=TL1; TR=TR1;output;
if State2=2 then do;case=5; TL=TR1;TR=TR2;output; end;
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if State2=3 then do;
case=5; TL=TR1;TR=TL2; output; case=6; TL=TL2;TR=TR2;output;
end;
if State2=4 then do;
case=5; TL=TR1;TR=TL2; output; case=7; TL=TL2;TR=TR2;output;
end;
end;
if State1=3 then do;
case=1; TL=0; TR=TL1;output; case=3; TL=TL1;TR=TR1; output;
end;
if State1=4 then do;
case=1; TL=0; TR=TL1;output; case=4; TL=TL1;TR=TR1; output;
end;
keep SimN id case TL TR Z;
Run;
Data SimD3; set SimD3; if TL ne TR; run;
Data C&Dataset; set SimD3; by SimN id;
if first.id then first=1;else first=0; if last.id then last=1; else last=0;
if TL=0 then TL=0.000001;
Run;
%Mend DataPrep;
/********************************************************************/
/*3. %Macro WLLike;*/
/********************************************************************/
%MACRO WLLike;
START logLikeWeibull(parms) global(Dataset);
lamda12=parms[1];lamda13=parms[2];lamda14=parms[3];int12=parms[4];
int13=parms[5]; int14=parms[6]; int23=parms[7];int24=parms[8];
Z12=parms[9];Z13=parms[10];Z14=parms[11];
logLike=.0; n=nrow(DataSet);
do i=1 to n;
case=DataSet[i,1];TL=DataSet[i,2];TR=DataSet[i,3];Z=DataSet[i,4];
first=DataSet[i,5];last=DataSet[i,6];
if first=1 then do;
expZ12=exp(int12+Z12*Z);expZ13=exp(int13+Z13*Z);
expZ14=exp(int14+Z14*Z); a23=exp(int23); a24=exp(int24);
end;
/*Case 1: 1->1*/
if case=1 then do;
A12TL=expZ12*(TL)**lamda12; A13TL=expZ13*(TL)**lamda13;
A14TL=expZ14*(TL)**lamda14;
A12TR=expZ12*(TR)**lamda12; A13TR=expZ13*(TR)**lamda13;
A14TR=expZ14*(TR)**lamda14;
logL=(A12TL+A13TL+A14TL)-(A12TR+A13TR+A14TR);
end;
/*Case 2: 1->2*/
if case=2 then do;
intg=.0; h=(TR-TL)/150;
do j=0 to 150;u=TL+j*h;
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*1. Get P11(TL,u);
A12TL=expZ12*(TL)**lamda12; A13TL=expZ13*(TL)**lamda13;
A14TL=expZ14*(TL)**lamda14;
A12u=expZ12*(u)**lamda12; A13u=expZ13*(u)**lamda13;
A14u=expZ14*(u)**lamda14;
p11=exp((A12TL+A13TL+A14TL)-(A12u+A13u+A14u));
*2. Get a12(u);
q12=expZ12*(lamda12)*(u)**(lamda12-1);
*3. Get p22(u,TR);
p22=exp(-(a23+a24)*(TR-u));
*4. do intergration p11(TL,u)*a12(u)*p22(u,TR);
f=p11*q12*p22; if j=0 | j=150 then intg=intg+f/2; else intg=intg+f;
end;
logL=log(intg*h);
end;
/*Case 3: 1->3*/
if case=3 then do;
intg=.0; h=(TR-TL)/150;
do j=0 to 150; u=TL+j*h;
*1. Get P11(TL,u);
A12TL=expZ12*(TL)**lamda12; A13TL=expZ13*(TL)**lamda13;
A14TL=expZ14*(TL)**lamda14;
A12u=expZ12*(u)**lamda12; A13u=expZ13*(u)**lamda13;
A14u=expZ14*(u)**lamda14;
p11=exp((A12TL+A13TL+A14TL)-(A12u+A13u+A14u));
*2. Get a12(u) a13(u);
q12=expZ12*(lamda12)*(u)**(lamda12-1);
q13=expZ13*(lamda13)*(u)**(lamda13-1);
*3. Get p23(u,TR);
p23= a23/(a23+a24)*(1-exp((a23+a24)*(u-TR)));
*4. do intergration p11(TL,u)*(a13(u)+a12(u)*p23(u,TR));
f=p11*(q12*p23+q13); if j=0 | j=150 then intg=intg+f/2; else intg=intg+f;
end;
logL=log(intg*h);
end;
/*Case 4: 1->4*/
if case=4 then do;
intg=.0; h=(TR-TL)/150;
*1. get p14(TL,TR)=p11(TL,TR)*a14(TR);
A12TL=expZ12*(TL)**lamda12; A13TL=expZ13*(TL)**lamda13;
A14TL=expZ14*(TL)**lamda14; A12TR=expZ12*(TR)**lamda12;
A13TR=expZ13*(TR)**lamda13; A14TR=expZ14*(TR)**lamda14;
p11TR=exp((A12TL+A13TL+A14TL)-(A12TR+A13TR+A14TR));
q14TR=expZ14*(lamda14)*(TR)**(lamda14-1); p14=p11TR*q14TR;
do j=0 to 150;
u=TL+j*h;
*1. Get P11(TL,u);
A12TL=expZ12*(TL)**lamda12; A13TL=expZ13*(TL)**lamda13;
A14TL=expZ14*(TL)**lamda14; A12u=expZ12*(u)**lamda12;
A13u=expZ13*(u)**lamda13;A14u=expZ14*(u)**lamda14;
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p11=exp((A12TL+A13TL+A14TL)-(A12u+A13u+A14u));
*2. Get a12(u);
q12=expZ12*(lamda12)*(u)**(lamda12-1);
*3. Get p24(u,TR);
p22=exp(-(a23+a24)*(TR-u));p24=p22*a24;
*4. do intergration p11(TL,u)*a12(u)*p24(u,TR));
f=p11*q12*p24; if j=0 | j=150 then intg=intg+f/2; else intg=intg+f;
end;
logL=log(p14+intg*h);
end;
/*Case 5: 2->2*/
if case=5 then logL=-(a23+a24)*(TR-TL);
/*Case 6: 2->3*/
if case=6 then do;
p23=(1-exp(-(a23+a24)*(TR-TL)))*a23/(a23+a24); logL=log(p23);
end;
/*Case 7: 2->4*/
if case=7 then logL=-(a23+a24)*(TR-TL)+log(a24);
logLike=logLike+logL;
end;
return(logLike);
FINISH logLikeWeibull;
%Mend WLLike;
/********************************************************************/
/*4. %Macro EstLJ(Dataset,Nsim,H0,Con); */
/********************************************************************/
%Macro EstLJ(Dataset,Nsim,H0,Con);
PROC IML;
%WLLike; &H0; &Con; optn={1 0 1 3}; ct={1000 1000}; Est=J(&Nsim,55,0);
use &Dataset;
do sim=1 to &Nsim;
read all var {Case TL TR Z First Last} into Dataset where(SimN=sim);
call nlpnra(rc,xres,"logLikeWeibull",h0,optn,con,ct); estimate=xres` ;
call nlpfdd(f,g,hes2,"logLikeWeibull",estimate);cov=-inv(hes2);
norqua=probit(1-0.05/2); stderr=sqrt(vecdiag(cov));
low=estimate-norqua*stderr; up=estimate+norqua*stderr;
z=abs(estimate/stderr);p=2*(1-probnorm(z));
Est[sim,1:11]=xres;Est[sim,12:22]=low`;Est[sim,23:33]=up`;
Est[sim,34:44]=p`;Est[sim,45:55]=stderr`;
end;
varNames={"lamda12" "lamda13" "lamda14" "int12" "int13" "int14" "int23"
"int24" "Z12" "Z13" "Z14" "lamda12CL" "lamda13CL" "lamda14CL" "int12CL"
"int13CL" "int14CL" "int23CL" "int24CL" "Z12CL" "Z13CL" "Z14CL"
"lamda12CU" "lamda13CU" "lamda14CU" "int12CU"
"int13CU" "int14CU" "int23CU" "int24CU" "Z12CU" "Z13CU" "Z14CU"
"lamda12p" "lamda13p" "lamda14p" "int12p" "int13p" "int14p" "int23p" "int24p"
"Z12p" "Z13p" "Z14p" "lamda12SD" "lamda13SD" "lamda14SD" "int12SD"
"int13SD" "int14SD" "int23SD" "int24SD" "Z12SD" "Z13SD" "Z14SD"};

90

create R&Dataset from Est[COLNAME=varNames] ;Append from Est; close
R&Dataset;
Quit;
%Mend;
/********************************************************************/
/*5. %Macro SimLJTable(Dataset);*/
/********************************************************************/
%Macro SimLJTable(Dataset);
Data SimT; Set &Dataset (keep=lamda13 Z12 Z13 Z14 Z12CL Z13CL Z14CL
Z12CU Z13CU Z14CU Z12SD Z13SD Z14SD);Beta1=2; Beta2=1.5; Beta3=0;
Ebeta1=Z12;Ebeta2=Z13;
Ebeta3=Z14; Bias1=Ebeta1-Beta1;Bias2=Ebeta2-Beta2;Bias3=Ebeta3-Beta3;
SE1=Bias1**2; SE2=Bias2**2;SE3=Bias3**2;
if Z12CL<=2 and Z12CU>=2 then Cbeta1=1; else Cbeta1=0;
if Z13CL<=1.5 and Z13CU>=1.5 then Cbeta2=1; else Cbeta2=0;
if Z14CL<=0 and Z14CU>=0 then Cbeta3=1; else Cbeta3=0;
where lamda13 ne 0.01; Run;
Proc tabulate data=SimT; var Z12 Z13 Z14 Z12SD Z13SD Z14SD Se1 Se2 Se3 Bias1
Bias2 Bias3 Cbeta1 Cbeta2 Cbeta3;
table (Z12 Z13 Z14)*(N mean*f=8.4 std*f=8.4) (Se1 Se2 Se3)*Mean*f=8.4
(Z12SD Z13SD Z14SD)*Mean*f=8.4 (Bias1 Bias2 Bias3)*Mean*f=8.4
(Cbeta1 Cbeta2 Cbeta3)*Mean*f=percentn10.2; Run;
%Mend;
/********************************************************************/
/*6. %Macro SimModel1LJ(Nsim,SubjN);*/
/********************************************************************/
%Macro SimModel1LJ(Nsim,SubjN);
%SimData(&Nsim,&SubjN);
/*1. Homogenous Data */
%DataPrep(SimH&SubjN);
%let h0H=%str(h0={1 1 1 -4.2 -4.3 -4 -1.5 -2 2 1.5 0};);
%let conH=%str(con={0.01 0.01 0.01 . . . . . . . ., . . . . . . . . . . .};);
%EstLJ(CSimH&SubjN,&Nsim,&H0H,&ConH); %SimLJTable(RCSimH&SubjN);
/*2. Weibull Data */
%DataPrep(SimW&SubjN);
%let H0W=%str(h0={1.9 2 2.1 -6.5 -6.7 -6 -1.5 -2 2 1.5 0};);
%let ConW=%str(con={1.00001 1.00001 1.00001 . . . . . . . ., . . . . . . . . . . .};);
%EstLJ(CSimW&SubjN,&Nsim,&H0W,&ConW);
%SimLJTable(RCSimW&SubjN);
/*3. Gomperz Data */
%DataPrep(SimG&SubjN);
%let H0G=%str(h0={3.5 5 5.5 -12.5 -17 -18 -1.5 -2 2 1.5 0};);
%let ConG=%str(con={1.00001 1.00001 1.00001 . . . . . . . ., . . . . . . . . . . .};);
%EstLJ(CSimG&SubjN,&Nsim,&H0G,&ConG);
%Mend SimModel1LJ;
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C. R codes for Semi-Markov model
library(rngWELL)
library(randtoolbox)
a12=function(t,pars) {return(pars[2]*pars[1]*(t^(pars[1]-1)))}
a13=function(t,pars) {return(pars[4]*pars[3]*(t^(pars[3]-1)))}
a14=function(t,pars) {return(pars[6]*pars[5]*(t^(pars[5]-1)))}
a23<-function(u1,t,cutage,pars) {
if (t>u1) {
if (t>cutage) res=pars[8]*pars[7]*(t-u1)^(pars[7]-1)*exp(pars[9])
else res=pars[8]*pars[7]*(t-u1)^(pars[7]-1)
}
else res=0
return(res)
}
a24<-function(u1,t,cutage,pars) {
if (t>u1) {
if (t>cutage) res=pars[11]*pars[10]*(t-u1)^(pars[10]-1)*exp(pars[12])
else res=pars[11]*pars[10]*(t-u1)^(pars[10]-1)
}
else res=0
return(res)
}
p11=function(t,pars)
return(exp(-pars[2]*(t^pars[1])-pars[4]*(t^pars[3])-pars[6]*(t^pars[5])))
p22=function(u1,u2,cutage,pars){
if (cutage>u2) A2=pars[8]*(u2-u1)^pars[7]+pars[11]*(u2-u1)^pars[10]
else if (cutage>u1) A2=pars[8]*exp(pars[9])*(u2-u1)^pars[7]
+pars[8]*(1-exp(pars[9]))*(cutage-u1)^pars[7]+ pars[11]*exp(pars[12])
*(u2-u1)^pars[10]+pars[11]*(1-exp(pars[12]))*(cutage-u1)^pars[10]
else A2=pars[8]*exp(pars[9])*(u2-u1)^pars[7]+pars[11]*exp(pars[12])
*(u2-u1)^pars[10]
return(exp(-A2))
}
#case 2: 1->2 or 1->2->2
p12<-function(t1,t2,t5,cutage,pars,SN){
pf12=function(u,t5,cutage,pars)
return(p11(u,pars)*a12(u,pars)*p22(u,t5,cutage,pars))
r1<-t1+(t2-t1)*halton(2*SN)
#r1<-t1+(t2-t1)*sobol(2*SN,scrambling=1)
res<-rep(0,SN)
for (i in 1:SN) res[i]=pf12(r1[i+SN],t5,cutage,pars)
return(mean(res)*(t2-t1))
}
#case 3: 1->3
p13<-function(t1,t2,cutage,pars,SN){
pf13<-function(u,pars) return(p11(u,pars)*a13(u,pars))
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pf123<-function(u1,u2,cutage,pars) {
p22e=ifelse(u2>u1,p22(u1,u2,cutage,pars)*a23(u1,u2,cutage,pars),0)
res=p11(u1,pars)*a12(u1,pars)*p22e
return(res)}
r1<-t1+(t2-t1)*halton(2*SN)
r2<-t1+(t2-t1)*halton(n=2*SN,dim=2)
#r1<-t1+(t2-t1)*sobol(2*SN,,scrambling=1)
#r2<-t1+(t2-t1)*sobol(n=2*SN,dim=2,,scrambling=1)
res1<-rep(0,SN)
res2<-rep(0,SN)
for (i in 1:SN) {
res1<-pf13(r1[i+SN],pars)
res2<-pf123(r2[i+SN,1],r2[i+SN,2],cutage,pars)
}
p1300=mean(res1)*(t2-t1)
p1230<-mean(res2)*(t2-t1)^2
return(p1300+p1230)
}
#case 4: 1->4
p14<-function(t,pars) return(p11(t,pars)*a14(t,pars))
#Case 5: 1->2->3
p123<-function(t1,t2,t3,t4,cutage,pars,SN){
pf123<-function(u1,u2,cutage,pars)
return(p11(u1,pars)*a12(u1,pars)*p22(u1,u2,cutage,pars)*a23(u1,u2,cutage,pars))
r1<-halton(2*SN,dim=2)
#r1<-sobol(2*SN,dim=2,,scrambling=1)
r1[,1]=t1+(t2-t1)*r1[,1]
r1[,2]=t3+(t4-t3)*r1[,2]
res<-rep(0,SN)
for (i in 1:SN) res[i]<-pf123(r1[i+SN,1],r1[i+SN,2],cutage,pars)
return(mean(res)*(t2-t1)*(t4-t3))
}
#Case 6: 1->2->4
p124<-function(t1,t2,t5,cutage,pars,SN){
pf124<-function(u,t5,cutage,pars)
return(p11(u,pars)*a12(u,pars)*p22(u,t5,cutage,pars)*a24(u,t5,cutage,pars))
r1<-t1+(t2-t1)*halton(2*SN)
#r1<-t1+(t2-t1)*sobol(2*SN,,scrambling=1)
res<-rep(0,SN)
for (i in 1:SN) res[i]<-pf124(r1[i+SN],t5,cutage,pars)
return(mean(res)*(t2-t1))
}
# Main log-likelihood function
logLSemi<-function(parms,dataset,cutage,SN) {
assign("dataset",dataset,envir=.GlobalEnv)
k12=parms[1];k13=parms[2];k14=parms[3]; k23=parms[4];k24=parms[5]
int12=parms[6]; int13=parms[7];int14=parms[8];int23=parms[9];int24=parms[10]
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par23_t=0;
par24_t=parms[11]
Apoe12=parms[12]; Female14=parms[13]
Sm14=parms[14]; Sm23=parms[15]
n=nrow(dataset);logLike=.0
for (i in 1:n){
case=dataset[i,1]
Bage=dataset[i,2]; t1=dataset[i,3]; t2=dataset[i,4]; t3=dataset[i,5]; t4=dataset[i,6];
t5=dataset[i,7];
Apoe=dataset[i,8];Female=dataset[i,9]; Educ=dataset[i,10]; Fam=dataset[i,11]
Db=dataset[i,12]; Sm=dataset[i,13];Hd=dataset[i,14]
expz12=exp(int12+Apoe12*Apoe)
expz13=exp(int13)
expz14=exp(int14+Female14*Female+Sm14*Sm)
expz23=exp(int23+Sm23*Sm)
expz24=exp(int24)
pars=c(k12,expz12,k13,expz13,k14,expz14,k23,expz23,par23_t,k24,
expz24,par24_t)
if (case==1) Li=p11(t5,pars)
else if (case==2) Li=p12(t1,t2,t5,cutage,pars,SN)
else if (case==3) Li=p13(t1,t2,cutage,pars,SN)
else if (case==4) Li=p14(t5,pars)
else if (case==5) Li=p123(t1,t2,t3,t4,cutage,pars,SN)
else Li=p124(t1,t2,t5,cutage,pars,SN)
logLike=logLike+log(Li)-log(p11(Bage,pars))
}
return(-logLike)
}
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